Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Stuart Franklin Schlossman, M.D.

TitleBaruj Benacerraf Professor of Medicine, Emeritus
InstitutionBeth Israel Deaconess Medical Center
DepartmentEmeritus
AddressDana Farber Cancer Institute
Division of Tumor Immunology
44 Binney St
Boston MA 02115
Phone617/632-3325
Fax617/632-2690

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Kung PC, Goldstein G, Reinherz EL, Schlossman SF. Pillars article: monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979. 206: 347-349. J Immunol. 2013 Jun 1; 190(11):5351-3.
    View in: PubMed
  2. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Pillars article: separation of functional subsets of human T cells by a monoclonal antibody. Proc. Natl. Acad. Sci. 1979. 76: 4061-4065. J Immunol. 2013 Jun 1; 190(11):5346-50.
    View in: PubMed
  3. Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, Schlossman SF. Pillars article: the CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. 1988. J Immunol. 2010 Sep 1; 185(5):2645-9.
    View in: PubMed
  4. Zola H, Swart B, Nicholson I, Aasted B, Bensussan A, Boumsell L, Buckley C, Clark G, Drbal K, Engel P, Hart D, Horejsí V, Isacke C, Macardle P, Malavasi F, Mason D, Olive D, Saalmueller A, Schlossman SF, Schwartz-Albiez R, Simmons P, Tedder TF, Uguccioni M, Warren H. CD molecules 2005: human cell differentiation molecules. Blood. 2005 Nov 1; 106(9):3123-6.
    View in: PubMed
  5. Xue L, Chu F, Cheng Y, Sun X, Borthakur A, Ramarao M, Pandey P, Wu M, Schlossman SF, Prasad KV. Siva-1 binds to and inhibits BCL-X(L)-mediated protection against UV radiation-induced apoptosis. Proc Natl Acad Sci U S A. 2002 May 14; 99(10):6925-30.
    View in: PubMed
  6. Zhang Y, Schlossman SF, Edwards RA, Ou CN, Gu J, Wu MX. Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2):878-83.
    View in: PubMed
  7. Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, Dang NH, Schlossman SF, Morimoto C. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc Natl Acad Sci U S A. 2001 Oct 9; 98(21):12138-43.
    View in: PubMed
  8. Ma F, Zhang C, Prasad KV, Freeman GJ, Schlossman SF. Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death. Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9778-83.
    View in: PubMed
  9. Jacquot S, Maçon-Lemaître L, Paris E, Kobata T, Tanaka Y, Morimoto C, Schlossman SF, Tron F. B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int Immunol. 2001 Jul; 13(7):871-6.
    View in: PubMed
  10. Marcus DM, Schlossman SF. In memoriam. Elvin Abraham Kabat, September 1, 1914-June 16, 2000. J Immunol. 2001 Mar 15; 166(6):3635-6.
    View in: PubMed
  11. Gensler TJ, Hottelet M, Zhang C, Schlossman S, Anderson P, Utz PJ. Monoclonal antibodies derived from BALB/c mice immunized with apoptotic Jurkat T cells recognize known autoantigens. J Autoimmun. 2001 Feb; 16(1):59-69.
    View in: PubMed
  12. He L, Gunn TM, Bouley DM, Lu XY, Watson SJ, Schlossman SF, Duke-Cohan JS, Barsh GS. A biochemical function for attractin in agouti-induced pigmentation and obesity. Nat Genet. 2001 Jan; 27(1):40-7.
    View in: PubMed
  13. Pozzi N, Gaetaniello L, Martire B, De Mattia D, Balestrieri B, Cosentini E, Schlossman SF, Duke-Cohan JS, Pignata C. Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2001 Jan; 123(1):99-104.
    View in: PubMed
  14. Ikushima H, Munakata Y, Ishii T, Iwata S, Terashima M, Tanaka H, Schlossman SF, Morimoto C. Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc Natl Acad Sci U S A. 2000 Jul 18; 97(15):8439-44.
    View in: PubMed
  15. Tang W, Gunn TM, McLaughlin DF, Barsh GS, Schlossman SF, Duke-Cohan JS. Secreted and membrane attractin result from alternative splicing of the human ATRN gene. Proc Natl Acad Sci U S A. 2000 May 23; 97(11):6025-30.
    View in: PubMed
  16. Morimoto S, Kanno Y, Tanaka Y, Tokano Y, Hashimoto H, Jacquot S, Morimoto C, Schlossman SF, Yagita H, Okumura K, Kobata T. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J Immunol. 2000 Apr 15; 164(8):4097-104.
    View in: PubMed
  17. Duke-Cohan JS, Tang W, Schlossman SF. Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. Adv Exp Med Biol. 2000; 477:173-85.
    View in: PubMed
  18. Barsh G, Gunn T, He L, Schlossman S, Duke-Cohan J. Biochemical and genetic studies of pigment-type switching. Pigment Cell Res. 2000; 13 Suppl 8:48-53.
    View in: PubMed
  19. Yoon Y, Ao Z, Cheng Y, Schlossman SF, Prasad KV. Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis. Oncogene. 1999 Nov 25; 18(50):7174-9.
    View in: PubMed
  20. Gu J, Dong RP, Zhang C, McLaughlin DF, Wu MX, Schlossman SF. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40. J Biol Chem. 1999 Jul 23; 274(30):20759-62.
    View in: PubMed
  21. Gunn TM, Miller KA, He L, Hyman RW, Davis RW, Azarani A, Schlossman SF, Duke-Cohan JS, Barsh GS. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature. 1999 Mar 11; 398(6723):152-6.
    View in: PubMed
  22. Iwata S, Yamaguchi N, Munakata Y, Ikushima H, Lee JF, Hosono O, Schlossman SF, Morimoto C. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. Int Immunol. 1999 Mar; 11(3):417-26.
    View in: PubMed
  23. Stuhler G, Zobywalski A, Grünebach F, Brossart P, Reichardt VL, Barth H, Stevanovic S, Brugger W, Kanz L, Schlossman SF. Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters. Proc Natl Acad Sci U S A. 1999 Feb 16; 96(4):1532-5.
    View in: PubMed
  24. Koester SK, Schlossman SF, Zhang C, Decker SJ, Bolton WE. APO2.7 defines a shared apoptotic-necrotic pathway in a breast tumor hypoxia model. Cytometry. 1998 Nov 1; 33(3):324-32.
    View in: PubMed
  25. Duke-Cohan JS, Gu J, McLaughlin DF, Xu Y, Freeman GJ, Schlossman SF. Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions. Proc Natl Acad Sci U S A. 1998 Sep 15; 95(19):11336-41.
    View in: PubMed
  26. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science. 1998 Aug 14; 281(5379):998-1001.
    View in: PubMed
  27. Zhang C, Xu Y, Gu J, Schlossman SF. A cell surface receptor defined by a mAb mediates a unique type of cell death similar to oncosis. Proc Natl Acad Sci U S A. 1998 May 26; 95(11):6290-5.
    View in: PubMed
  28. Morimoto C, Schlossman SF. The structure and function of CD26 in the T-cell immune response. Immunol Rev. 1998 Feb; 161:55-70.
    View in: PubMed
  29. Dong RP, Tachibana K, Hegen M, Scharpé S, Cho D, Schlossman SF, Morimoto C. Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function. Mol Immunol. 1998 Jan; 35(1):13-21.
    View in: PubMed
  30. Dong RP, Tachibana K, Hegen M, Munakata Y, Cho D, Schlossman SF, Morimoto C. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. J Immunol. 1997 Dec 15; 159(12):6070-6.
    View in: PubMed
  31. Wu MX, Schlossman SF. Decreased ability of HIV-1 tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells. Proc Natl Acad Sci U S A. 1997 Dec 9; 94(25):13832-7.
    View in: PubMed
  32. Koester SK, Roth P, Mikulka WR, Schlossman SF, Zhang C, Bolton WE. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry. 1997 Dec 1; 29(4):306-12.
    View in: PubMed
  33. Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J Immunol. 1997 Sep 15; 159(6):2652-7.
    View in: PubMed
  34. Wu MX, Ao Z, Daley JF, Schlossman SF. Induction and detection of apoptosis in human periphery blood T-cells. J Immunol Methods. 1997 Aug 7; 206(1-2):153-62.
    View in: PubMed
  35. Jacquot S, Kobata T, Iwata S, Schlossman SF, Morimoto C. CD27/CD70 interaction contributes to the activation and the function of human autoreactive CD27+ regulatory T cells. Cell Immunol. 1997 Jul 10; 179(1):48-54.
    View in: PubMed
  36. Seth A, Zhang C, Letvin NL, Schlossman SF. Detection of apoptotic cells from peripheral blood of HIV-infected individuals using a novel monoclonal antibody. AIDS. 1997 Jul; 11(8):1059-61.
    View in: PubMed
  37. Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S, Schlossman SF. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci U S A. 1997 Jun 10; 94(12):6346-51.
    View in: PubMed
  38. Dong RP, Umezawa Y, Ikushima H, Munakata Y, Schlossman SF, Morimoto C. Different regulatory effects of pentoxifylline on human T cell activation pathways. J Clin Immunol. 1997 May; 17(3):247-52.
    View in: PubMed
  39. Meehan SM, McCluskey RT, Pascual M, Preffer FI, Anderson P, Schlossman SF, Colvin RB. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. Lab Invest. 1997 May; 76(5):639-49.
    View in: PubMed
  40. Hegen M, Kameoka J, Dong RP, Schlossman SF, Morimoto C. Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology. 1997 Feb; 90(2):257-64.
    View in: PubMed
  41. Stuhler G, Schlossman SF. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. Proc Natl Acad Sci U S A. 1997 Jan 21; 94(2):622-7.
    View in: PubMed
  42. Hegen M, Kameoka J, Dong RP, Morimoto C, Schlossman SF. Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation. Adv Exp Med Biol. 1997; 421:109-16.
    View in: PubMed
  43. Zhang C, Ao Z, Seth A, Schlossman SF. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol. 1996 Nov 1; 157(9):3980-7.
    View in: PubMed
  44. Wu MX, Ao Z, Hegen M, Morimoto C, Schlossman SF. Requirement of Fas(CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells. J Immunol. 1996 Jul 15; 157(2):707-13.
    View in: PubMed
  45. Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol. 1996 Mar 1; 156(5):1714-21.
    View in: PubMed
  46. Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, Morimoto C. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol. 1996 Feb 15; 156(4):1349-55.
    View in: PubMed
  47. Medley QG, Kedersha N, O'Brien S, Tian Q, Schlossman SF, Streuli M, Anderson P. Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci U S A. 1996 Jan 23; 93(2):685-9.
    View in: PubMed
  48. Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C. CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci U S A. 1995 Nov 21; 92(24):11249-53.
    View in: PubMed
  49. Zhang C, Robertson MJ, Schlossman SF. A triplet of nuclease proteins (NP42-50) is activated in human Jurkat cells undergoing apoptosis. Cell Immunol. 1995 Oct 15; 165(2):161-7.
    View in: PubMed
  50. Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26). J Biol Chem. 1995 Jun 9; 270(23):14107-14.
    View in: PubMed
  51. Agematsu K, Kobata T, Sugita K, Hirose T, Schlossman SF, Morimoto C. Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. J Immunol. 1995 Apr 15; 154(8):3627-35.
    View in: PubMed
  52. Nojima Y, Tachibana K, Sato T, Schlossman SF, Morimoto C. Focal adhesion kinase (pp125FAK) is tyrosine phosphorylated after engagement of alpha 4 beta 1 and alpha 5 beta 1 integrins on human T-lymphoblastic cells. Cell Immunol. 1995 Mar; 161(1):8-13.
    View in: PubMed
  53. Wu MX, Daley JF, Rasmussen RA, Schlossman SF. Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1525-9.
    View in: PubMed
  54. Kameoka J, Sato T, Torimoto Y, Sugita K, Soiffer RJ, Schlossman SF, Ritz J, Morimoto C. Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation. Blood. 1995 Feb 15; 85(4):1132-7.
    View in: PubMed
  55. Kobata T, Agematsu K, Kameoka J, Schlossman SF, Morimoto C. CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation. J Immunol. 1994 Dec 15; 153(12):5422-32.
    View in: PubMed
  56. Kurosawa K, Kobata T, Tachibana K, Agematsu K, Hirose T, Schlossman SF, Morimoto C. Differential regulation of CD27 expression on subsets of CD4 T cells. Cell Immunol. 1994 Oct 15; 158(2):365-75.
    View in: PubMed
  57. Morimoto C, Lord CI, Zhang C, Duke-Cohan JS, Letvin NL, Schlossman SF. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc Natl Acad Sci U S A. 1994 Oct 11; 91(21):9960-4.
    View in: PubMed
  58. Agematsu K, Kobata T, Sugita K, Freeman GJ, Beckmann MP, Schlossman SF, Morimoto C. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. J Immunol. 1994 Aug 15; 153(4):1421-9.
    View in: PubMed
  59. Sugita K, Nojima Y, Tachibana K, Soiffer RJ, Murray C, Schlossman SF, Ritz J, Morimoto C. Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation. J Clin Invest. 1994 Aug; 94(2):481-8.
    View in: PubMed
  60. Hirose T, Kobata T, Nojima Y, Schlossman SF, Morimoto C. 3H11, a unique cell surface molecule involved in the function of the CD45RA+ subset of CD4+ cells. Int Immunol. 1994 Aug; 6(8):1133-42.
    View in: PubMed
  61. Sugita K, Soiffer RJ, Murray C, Schlossman SF, Ritz J, Morimoto C. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation. Transplantation. 1994 May 27; 57(10):1465-73.
    View in: PubMed
  62. Tanaka T, Duke-Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF, Morimoto C. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci U S A. 1994 Apr 12; 91(8):3082-6.
    View in: PubMed
  63. Pulido R, Schlossman SF, Saito H, Streuli M. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities. J Exp Med. 1994 Mar 1; 179(3):1035-40.
    View in: PubMed
  64. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, et al. CD antigens 1993. Immunol Today. 1994 Mar; 15(3):98-9.
    View in: PubMed
  65. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, et al. CD antigens 1993. Blood. 1994 Feb 15; 83(4):879-80.
    View in: PubMed
  66. Rasmussen RA, Counts SL, Daley JF, Schlossman SF. Isolation and characterization of CD6- T cells from peripheral blood. J Immunol. 1994 Jan 15; 152(2):527-36.
    View in: PubMed
  67. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, et al. CD antigens 1993. J Immunol. 1994 Jan 1; 152(1):1-2.
    View in: PubMed
  68. Sugita K, Tanaka T, Doshen JM, Schlossman SF, Morimoto C. Direct demonstration of the CD27 molecule involved in the negative regulatory effect on T cell activation. Cell Immunol. 1993 Nov; 152(1):279-85.
    View in: PubMed
  69. Nojima Y, Hirose T, Tachibana K, Tanaka T, Shi L, Doshen J, Freeman GJ, Schlossman SF, Morimoto C. The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. Cell Immunol. 1993 Nov; 152(1):249-60.
    View in: PubMed
  70. Duke-Cohan JS, Morimoto C, Schlossman SF. Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29. Transplantation. 1993 Nov; 56(5):1188-96.
    View in: PubMed
  71. Sugita K, Dasgupta JD, Nojima Y, Agematsu K, Schlossman SF, Morimoto C. Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27. Immunology. 1993 Oct; 80(2):217-21.
    View in: PubMed
  72. Duke-Cohan JS, Morimoto C, Schlossman SF. Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26. Blood. 1993 Oct 1; 82(7):2224-34.
    View in: PubMed
  73. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science. 1993 Jul 23; 261(5120):466-9.
    View in: PubMed
  74. Tenner-Racz K, Racz P, Thomé C, Meyer CG, Anderson PJ, Schlossman SF, Letvin NL. Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. Am J Pathol. 1993 Jun; 142(6):1750-8.
    View in: PubMed
  75. Tanaka T, Kameoka J, Yaron A, Schlossman SF, Morimoto C. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci U S A. 1993 May 15; 90(10):4586-90.
    View in: PubMed
  76. Morimoto C, Schlossman SF. P. Rambotti Lecture. Human naive and memory T cells revisited: new markers (CD31 and CD27) that help define CD4+ T cell subsets. Clin Exp Rheumatol. 1993 May-Jun; 11(3):241-7.
    View in: PubMed
  77. Rothstein DM, da Silva A, Sugita K, Yamamoto M, Prasad KV, Morimoto C, Schlossman SF, Rudd CE. Human CD4/CD45RA+ and CD4/CD45RA- T cell subsets express CD4-p56lck complexes, CD4-associated lipid kinases, TCR/CD3-p59fyn complexes, and share similar tyrosine kinase substrates. Int Immunol. 1993 Apr; 5(4):409-18.
    View in: PubMed
  78. Sugita K, Hirose T, Rothstein DM, Donahue C, Schlossman SF, Morimoto C. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. J Immunol. 1992 Nov 15; 149(10):3208-16.
    View in: PubMed
  79. Torimoto Y, Dang NH, Streuli M, Rothstein DM, Saito H, Schlossman SF, Morimoto C. Activation of T cells through a T cell-specific epitope of CD45. Cell Immunol. 1992 Nov; 145(1):111-29.
    View in: PubMed
  80. Kawakami A, Tian Q, Duan X, Streuli M, Schlossman SF, Anderson P. Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A. 1992 Sep 15; 89(18):8681-5.
    View in: PubMed
  81. Sugita K, Robertson MJ, Torimoto Y, Ritz J, Schlossman SF, Morimoto C. Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J Immunol. 1992 Aug 15; 149(4):1199-203.
    View in: PubMed
  82. Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C. Cloning and functional expression of the T cell activation antigen CD26. J Immunol. 1992 Jul 15; 149(2):481-6.
    View in: PubMed
  83. Rothstein DM, Saito H, Streuli M, Schlossman SF, Morimoto C. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. J Biol Chem. 1992 Apr 5; 267(10):7139-47.
    View in: PubMed
  84. Nojima Y, Rothstein DM, Sugita K, Schlossman SF, Morimoto C. Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein. J Exp Med. 1992 Apr 1; 175(4):1045-53.
    View in: PubMed
  85. Torimoto Y, Dang NH, Tanaka T, Prado C, Schlossman SF, Morimoto C. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol Immunol. 1992 Feb; 29(2):183-92.
    View in: PubMed
  86. Torimoto Y, Rothstein DM, Dang NH, Schlossman SF, Morimoto C. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J Immunol. 1992 Jan 15; 148(2):388-96.
    View in: PubMed
  87. Vivier E, Rochet N, Kochan JP, Presky DH, Schlossman SF, Anderson P. Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes. J Immunol. 1991 Dec 15; 147(12):4263-70.
    View in: PubMed
  88. Dang NH, Torimoto Y, Shimamura K, Tanaka T, Daley JF, Schlossman SF, Morimoto C. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J Immunol. 1991 Nov 1; 147(9):2825-32.
    View in: PubMed
  89. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell. 1991 Nov 1; 67(3):629-39.
    View in: PubMed
  90. Sohen S, Romain PL, Rothstein DM, Yamane T, Tanaka S, Anderson P, Schlossman SF, Morimoto C. Phenotypic abnormalities in CD8+ T lymphocyte subsets in patients with rheumatoid arthritis. J Rheumatol. 1991 Nov; 18(11):1649-54.
    View in: PubMed
  91. Matsuyama T, Yamada A, Rothstein DM, Anderson KC, Schlossman SF, Morimoto C. CD45 isoforms associated with distinct functions of CD4 cells derived from unusual healthy donors lacking CD45RA- T lymphocytes. Cell Immunol. 1991 Oct 15; 137(2):406-19.
    View in: PubMed
  92. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol. 1991 Oct 15; 147(8):2514-7.
    View in: PubMed
  93. Sugita K, Torimoto Y, Nojima Y, Daley JF, Schlossman SF, Morimoto C. The 1A4 molecule (CD27) is involved in T cell activation. J Immunol. 1991 Sep 1; 147(5):1477-83.
    View in: PubMed
  94. Burgess KE, Odysseos AD, Zalvan C, Druker BJ, Anderson P, Schlossman SF, Rudd CE. Biochemical identification of a direct physical interaction between the CD4:p56lck and Ti(TcR)/CD3 complexes. Eur J Immunol. 1991 Jul; 21(7):1663-8.
    View in: PubMed
  95. Torimoto Y, Sugita K, Weinberg DS, Dang NH, Donahue C, Letvin NL, Schlossman SF, Morimoto C. Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells. J Immunol. 1991 Apr 1; 146(7):2176-84.
    View in: PubMed
  96. Vivier E, Morin PM, O'Brien C, Schlossman SF, Anderson P. CD2 is functionally linked to the zeta-natural killer receptor complex. Eur J Immunol. 1991 Apr; 21(4):1077-80.
    View in: PubMed
  97. Egea E, Iglesias A, Salazar M, Morimoto C, Kruskall MS, Awdeh Z, Schlossman SF, Alper CA, Yunis EJ. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med. 1991 Mar 1; 173(3):531-8.
    View in: PubMed
  98. Vivier E, Morin P, Tian QS, Daley J, Blue ML, Schlossman SF, Anderson P. Expression and tyrosine phosphorylation of the T cell receptor zeta-subunit in human thymocytes. J Immunol. 1991 Feb 15; 146(4):1142-8.
    View in: PubMed
  99. Rothstein DM, Yamada A, Schlossman SF, Morimoto C. Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line. J Immunol. 1991 Feb 15; 146(4):1175-83.
    View in: PubMed
  100. Yamada A, Nojima Y, Sugita K, Dang NH, Schlossman SF, Morimoto C. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system. Eur J Immunol. 1991 Feb; 21(2):319-25.
    View in: PubMed
  101. Yamada A, Nikaido T, Nojima Y, Schlossman SF, Morimoto C. Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J Immunol. 1991 Jan 1; 146(1):53-6.
    View in: PubMed
  102. Rudd CE, Barber EK, Burgess KE, Hahn JY, Odysseos AD, Sy MS, Schlossman SF. Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigens. Adv Exp Med Biol. 1991; 292:85-96.
    View in: PubMed
  103. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, Anderson P. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol. 1991 Jan 1; 146(1):206-10.
    View in: PubMed
  104. Dang NH, Torimoto Y, Sugita K, Daley JF, Schow P, Prado C, Schlossman SF, Morimoto C. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol. 1990 Dec 15; 145(12):3963-71.
    View in: PubMed
  105. Nojima Y, Humphries MJ, Mould AP, Komoriya A, Yamada KM, Schlossman SF, Morimoto C. VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin. J Exp Med. 1990 Oct 1; 172(4):1185-92.
    View in: PubMed
  106. Rothstein DM, Sohen S, Daley JF, Schlossman SF, Morimoto C. CD4+CD45RA+ and CD4+CD45RA- T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with Con A. Cell Immunol. 1990 Sep; 129(2):449-67.
    View in: PubMed
  107. Dang NH, Torimoto Y, Schlossman SF, Morimoto C. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J Exp Med. 1990 Aug 1; 172(2):649-52.
    View in: PubMed
  108. Yamada A, Streuli M, Saito H, Rothstein DM, Schlossman SF, Morimoto C. Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phosphatase activity in T cells. Eur J Immunol. 1990 Aug; 20(8):1655-60.
    View in: PubMed
  109. Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol. 1990 Jun 1; 144(11):4092-100.
    View in: PubMed
  110. Sohen S, Rothstein DM, Tallman T, Gaudette D, Schlossman SF, Morimoto C. The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies. Cell Immunol. 1990 Jun; 128(1):314-28.
    View in: PubMed
  111. Tedder TF, Matsuyama T, Rothstein D, Schlossman SF, Morimoto C. Human antigen-specific memory T cells express the homing receptor (LAM-1) necessary for lymphocyte recirculation. Eur J Immunol. 1990 Jun; 20(6):1351-5.
    View in: PubMed
  112. Sleasman JW, Morimoto C, Schlossman SF, Tedder TF. The role of functionally distinct helper T lymphocyte subpopulations in the induction of human B cell differentiation. Eur J Immunol. 1990 Jun; 20(6):1357-66.
    View in: PubMed
  113. Deusch K, Daley JF, Levine H, Languet AJ, Anderson P, Schlossman SF, Blue ML. Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface molecules. J Immunol. 1990 Apr 15; 144(8):2851-8.
    View in: PubMed
  114. Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF. Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci U S A. 1990 Mar; 87(6):2274-8.
    View in: PubMed
  115. Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter HS, Blue ML, Schlossman SF. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol. 1990 Jan 15; 144(2):574-82.
    View in: PubMed
  116. Dang NH, Hafler DA, Schlossman SF, Breitmeyer JB. FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation. Cell Immunol. 1990 Jan; 125(1):42-57.
    View in: PubMed
  117. Morimoto C, Torimoto Y, Levinson G, Rudd CE, Schrieber M, Dang NH, Letvin NL, Schlossman SF. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol. 1989 Dec 1; 143(11):3430-9.
    View in: PubMed
  118. Reimann KA, Turner S, Lambert JM, Reed MH, Schlossman SF, Letvin NL. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. V. Evidence that humoral immune response to monoclonal antibodies and immunotoxin conjugates abrogates their cytotoxic activity. Transplantation. 1989 Dec; 48(6):906-12.
    View in: PubMed
  119. Swack JA, Gangemi RM, Rudd CE, Morimoto C, Schlossman SF, Romain PL. Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation. Mol Immunol. 1989 Nov; 26(11):1037-49.
    View in: PubMed
  120. Matsuyama T, Yamada A, Kay J, Yamada KM, Akiyama SK, Schlossman SF, Morimoto C. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med. 1989 Oct 1; 170(4):1133-48.
    View in: PubMed
  121. Rudd CE, Anderson P, Morimoto C, Streuli M, Schlossman SF. Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation. Immunol Rev. 1989 Oct; 111:225-66.
    View in: PubMed
  122. Anderson P, Blue ML, O'Brien C, Schlossman SF. Monoclonal antibodies reactive with the T cell receptor zeta chain: production and characterization using a new method. J Immunol. 1989 Sep 15; 143(6):1899-904.
    View in: PubMed
  123. Anderson P, Caligiuri M, Ritz J, Schlossman SF. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex. Nature. 1989 Sep 14; 341(6238):159-62.
    View in: PubMed
  124. Morimoto C, Takeuchi T, Schlossman SF. Characterization of the CD8+CD45R+(2H4+) suppressor effector cell. Clin Exp Rheumatol. 1989 Sep-Oct; 7 Suppl 3:S3-7.
    View in: PubMed
  125. Rudd C, Helms S, Barber EK, Schlossman SF. The CD4/CD8:p56lck complex in T lymphocytes: a potential mechanism to regulate T-cell growth. Biochem Cell Biol. 1989 Sep; 67(9):581-9.
    View in: PubMed
  126. Scott CF, Bolender S, McIntyre GD, Holldack J, Lambert JM, Venkatesh YP, Morimoto C, Ritz J, Schlossman SF. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells. J Immunol. 1989 Jun 1; 142(11):4105-12.
    View in: PubMed
  127. Barber EK, Dasgupta JD, Schlossman SF, Trevillyan JM, Rudd CE. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci U S A. 1989 May; 86(9):3277-81.
    View in: PubMed
  128. Bosserman LD, Murray C, Takvorian T, Anderson KC, Freedman AS, Fitzsimmons J, Coral F, Nadler LM, Schlossman SF, Ritz J. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. Bone Marrow Transplant. 1989 May; 4(3):239-45.
    View in: PubMed
  129. Blue ML, Levine H, Daley JF, Branton KR, Schlossman SF. Expression of CD1 and class I MHC antigens by human thymocytes. J Immunol. 1989 Apr 15; 142(8):2714-20.
    View in: PubMed
  130. Tedder TF, Disteche CM, Louie E, Adler DA, Croce CM, Schlossman SF, Saito H. The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14)(q13;q32) translocation site. J Immunol. 1989 Apr 1; 142(7):2555-9.
    View in: PubMed
  131. Takeuchi T, Rudd CE, Tanaka S, Rothstein DM, Schlossman SF, Morimoto C. Functional characterization of the CD45R (2H4) molecule on CD8 (T8) cells in the autologous mixed lymphocyte reaction system. Eur J Immunol. 1989 Apr; 19(4):747-55.
    View in: PubMed
  132. Tedder TF, Klejman G, Schlossman SF, Saito H. Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J Immunol. 1989 Apr 1; 142(7):2560-8.
    View in: PubMed
  133. Tanaka S, Matsuyama T, Steinberg AD, Schlossman SF, Morimoto C. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus. Arthritis Rheum. 1989 Apr; 32(4):398-405.
    View in: PubMed
  134. Blue ML, Daley JF, Levine H, Branton KR, Schlossman SF. Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor. J Immunol. 1989 Jan 15; 142(2):374-80.
    View in: PubMed
  135. Takeuchi T, Rudd CE, Tedder TF, Schlossman SF, Morimoto C. Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen. Cell Immunol. 1989 Jan; 118(1):68-84.
    View in: PubMed
  136. Tedder TF, Klejman G, Disteche CM, Adler DA, Schlossman SF, Saito H. Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen, and localization of the gene to chromosome 19. J Immunol. 1988 Dec 15; 141(12):4388-94.
    View in: PubMed
  137. Streuli M, Morimoto C, Schrieber M, Schlossman SF, Saito H. Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. J Immunol. 1988 Dec 1; 141(11):3910-4.
    View in: PubMed
  138. Tedder TF, McIntyre G, Schlossman SF. Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytes. Mol Immunol. 1988 Dec; 25(12):1321-30.
    View in: PubMed
  139. Takeuchi T, Schlossman SF, Morimoto C. Development of an antigen-specific CD8 suppressor effector clone in man. J Immunol. 1988 Nov 1; 141(9):3010-5.
    View in: PubMed
  140. Streuli M, Krueger NX, Hall LR, Schlossman SF, Saito H. A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J Exp Med. 1988 Nov 1; 168(5):1523-30.
    View in: PubMed
  141. Hall LR, Streuli M, Schlossman SF, Saito H. Complete exon-intron organization of the human leukocyte common antigen (CD45) gene. J Immunol. 1988 Oct 15; 141(8):2781-7.
    View in: PubMed
  142. Takeuchi T, Tanaka S, Steinberg AD, Matsuyama T, Daley J, Schlossman SF, Morimoto C. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. J Clin Invest. 1988 Oct; 82(4):1288-94.
    View in: PubMed
  143. Matsuyama T, Anderson P, Daley JF, Schlossman S, Morimoto C. CD4+CD45R+ cells are preferentially activated through the CD2 pathway. Eur J Immunol. 1988 Sep; 18(9):1473-6.
    View in: PubMed
  144. Anderson P, Blue ML, Morimoto C, Schlossman SF. Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation. Cell Immunol. 1988 Sep; 115(2):246-56.
    View in: PubMed
  145. Blue ML, Craig KA, Anderson P, Branton KR, Schlossman SF. Evidence for specific association between class I major histocompatibility antigens and the CD8 molecules of human suppressor/cytotoxic cells. Cell. 1988 Jul 29; 54(3):413-21.
    View in: PubMed
  146. Tedder TF, Schlossman SF. Phosphorylation of the B1 (CD20) molecule by normal and malignant human B lymphocytes. J Biol Chem. 1988 Jul 15; 263(20):10009-15.
    View in: PubMed
  147. Anderson P, Morimoto C, Breitmeyer JB, Schlossman SF. Regulatory interactions between members of the immunoglobulin superfamily. Immunol Today. 1988 Jul-Aug; 9(7-8):199-203.
    View in: PubMed
  148. Reimann KA, Goldmacher VS, Lambert JM, Chalifoux LV, Cook SB, Schlossman SF, Letvin NL. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin. J Clin Invest. 1988 Jul; 82(1):129-38.
    View in: PubMed
  149. Hafler DA, Ritz J, Schlossman SF, Weiner HL. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. J Immunol. 1988 Jul 1; 141(1):131-8.
    View in: PubMed
  150. Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, Schlossman SF. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc Natl Acad Sci U S A. 1988 Jul; 85(14):5190-4.
    View in: PubMed
  151. Michon JM, Caligiuri MA, Hazanow SM, Levine H, Schlossman SF, Ritz J. Induction of natural killer effectors from human thymus with recombinant IL-2. J Immunol. 1988 May 15; 140(10):3660-7.
    View in: PubMed
  152. Morimoto C, Matsuyama T, Rudd CE, Forsgren A, Letvin NL, Schlossman SF. Role of the 2H4 molecule in the activation of suppressor inducer function. Eur J Immunol. 1988 May; 18(5):731-7.
    View in: PubMed
  153. Matsushita S, Morimoto C, Schlossman SF, Sasazuki T. Monoclonal antibody 4B4 blocks suppression of the immune response to Cryptomeria japonica pollen antigen. Hum Immunol. 1988 May; 22(1):1-7.
    View in: PubMed
  154. Scott CF, Blättler WA, Lambert JM, Kalish RS, Morimoto C, Schlossman SF. Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells. J Clin Invest. 1988 May; 81(5):1427-33.
    View in: PubMed
  155. Morimoto C, Romain PL, Fox DA, Anderson P, DiMaggio M, Levine H, Schlossman SF. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases. Am J Med. 1988 May; 84(5):817-25.
    View in: PubMed
  156. Morimoto C, Rudd CE, Letvin NL, Hagan M, Schlossman SF. 2H1--a novel antigen involved in T lymphocyte triggering. J Immunol. 1988 Apr 1; 140(7):2165-70.
    View in: PubMed
  157. Anderson P, Blue ML, Schlossman SF. Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytes. J Immunol. 1988 Mar 15; 140(6):1732-7.
    View in: PubMed
  158. Forsgren A, Penta A, Schlossman SF, Tedder TF. Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. Cell Immunol. 1988 Mar; 112(1):78-88.
    View in: PubMed
  159. Takeuchi T, DiMaggio M, Levine H, Schlossman SF, Morimoto C. CD11 molecule defines two types of suppressor cells within the T8+ population. Cell Immunol. 1988 Feb; 111(2):398-409.
    View in: PubMed
  160. Kalish RS, Morimoto C, Schlossman SF. Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4- inducer cells. Cell Immunol. 1988 Feb; 111(2):379-89.
    View in: PubMed
  161. Blue ML, Hafler DA, Daley JF, Levine H, Craig KA, Breitmeyer JB, Schlossman SF. Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities. J Immunol. 1988 Jan 15; 140(2):376-83.
    View in: PubMed
  162. Scott CF, Lambert JM, Kalish RS, Morimoto C, Schlossman SF. Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway. J Immunol. 1988 Jan 1; 140(1):8-14.
    View in: PubMed
  163. Ritz J, Schmidt RE, Michon J, Hercend T, Schlossman SF. Characterization of functional surface structures on human natural killer cells. Adv Immunol. 1988; 42:181-211.
    View in: PubMed
  164. Tedder TF, Streuli M, Schlossman SF, Saito H. Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci U S A. 1988 Jan; 85(1):208-12.
    View in: PubMed
  165. Anderson P, Morimoto C, Blue ML, Streuli M, Saito H, Schlossman SF. Lymphocyte activation: modulatory effects mediated by interactions between cell adhesion molecules. Ann N Y Acad Sci. 1988; 551:347-52; discussion 353.
    View in: PubMed
  166. Blue ML, Hafler DA, Craig KA, Levine H, Schlossman SF. Phosphorylation of CD4 and CD8 molecules following T cell triggering. J Immunol. 1987 Dec 15; 139(12):3949-54.
    View in: PubMed
  167. Morimoto C, Rudd CE, Letvin NL, Schlossman SF. A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells. Nature. 1987 Dec 3-9; 330(6147):479-82.
    View in: PubMed
  168. Rudd CE, Morimoto C, Wong LL, Schlossman SF. The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens. J Exp Med. 1987 Dec 1; 166(6):1758-73.
    View in: PubMed
  169. Streuli M, Hall LR, Saga Y, Schlossman SF, Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med. 1987 Nov 1; 166(5):1548-66.
    View in: PubMed
  170. Breitmeyer JB, Daley JF, Levine HB, Schlossman SF. The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells. J Immunol. 1987 Nov 1; 139(9):2899-905.
    View in: PubMed
  171. Streuli M, Matsuyama T, Morimoto C, Schlossman SF, Saito H. Identification of the sequence required for expression of the 2H4 epitope on the human leukocyte common antigens. J Exp Med. 1987 Nov 1; 166(5):1567-72.
    View in: PubMed
  172. Morimoto C, Schlossman SF. The human immunoregulatory T cell circuit: recent progress and its clinical implications. Keio J Med. 1987 Oct; 36(4):351-68.
    View in: PubMed
  173. Blue ML, Daley JF, Levine H, Craig KA, Schlossman SF. Identification and isolation of a T4+T8+ cell with high T3 expression in human thymus: a possible late intermediate in thymocyte differentiation. J Immunol. 1987 Aug 15; 139(4):1065-9.
    View in: PubMed
  174. Anderson P, Blue ML, Morimoto C, Schlossman SF. Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. J Immunol. 1987 Aug 1; 139(3):678-82.
    View in: PubMed
  175. Takeuchi T, Schlossman SF, Morimoto C. The T4 molecule differentially regulating the activation of subpopulations of T4+ cells. J Immunol. 1987 Aug 1; 139(3):665-71.
    View in: PubMed
  176. Takeuchi T, Schlossman SF, Morimoto C. The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system. Cell Immunol. 1987 Jun; 107(1):107-14.
    View in: PubMed
  177. Blue ML, Daley JF, Levine H, Craig KA, Schlossman SF. Activation of immature cortical thymocytes through the T11 sheep erythrocyte binding protein. J Immunol. 1987 May 15; 138(10):3108-13.
    View in: PubMed
  178. Blue ML, Levine H, Daley JF, Craig KA, Schlossman SF. Development of natural killer cells in human thymocyte culture: regulation by accessory cells. Eur J Immunol. 1987 May; 17(5):669-73.
    View in: PubMed
  179. Forsgren A, Bredberg A, Pardee AB, Schlossman SF, Tedder TF. Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother. 1987 May; 31(5):774-9.
    View in: PubMed
  180. Forsgren A, Schlossman SF, Tedder TF. 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob Agents Chemother. 1987 May; 31(5):768-73.
    View in: PubMed
  181. Morimoto C, Steinberg AD, Letvin NL, Hagan M, Takeuchi T, Daley J, Levine H, Schlossman SF. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest. 1987 Mar; 79(3):762-8.
    View in: PubMed
  182. Milford EL, Carpenter CB, Kirkman RL, Tilney NL, Mazoujian G, Strom TB, Lazarus JM, Schlossman SF, Guttmann RD, Lowry R, et al. Anti-T12 monoclonal antibody therapy of acute renal allograft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 3):1910.
    View in: PubMed
  183. Anderson KC, Ritz J, Takvorian T, Coral F, Daley H, Gorgone BC, Freedman AS, Canellos GP, Schlossman SF, Nadler LM. Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood. 1987 Feb; 69(2):597-604.
    View in: PubMed
  184. Breitmeyer JB, Oppenheim SO, Daley JF, Levine HB, Schlossman SF. Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex. J Immunol. 1987 Feb 1; 138(3):726-31.
    View in: PubMed
  185. Blue ML, Daley JF, Levine H, Craig KA, Schlossman SF. Characterization of the T3+T4+T8+ thymocyte intermediate in vitro. Cell Immunol. 1987 Feb; 104(2):223-31.
    View in: PubMed
  186. Morimoto C, Schlossman SF. Antilymphocyte antibodies and systemic lupus erythematosus. Arthritis Rheum. 1987 Feb; 30(2):225-8.
    View in: PubMed
  187. Morimoto C, Hafler DA, Weiner HL, Letvin NL, Hagan M, Daley J, Schlossman SF. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N Engl J Med. 1987 Jan 8; 316(2):67-72.
    View in: PubMed
  188. Scott CF, Lambert JM, Goldmacher VS, Blatter WA, Sobel R, Schlossman SF, Benacerraf B. The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodies. Int J Immunopharmacol. 1987; 9(2):211-25.
    View in: PubMed
  189. Anderson KC, Nadler LM, Takvorian T, Freedman AS, Canellos GP, Schlossman SF, Ritz J. Monoclonal antibodies: their use in bone marrow transplantation. Prog Hematol. 1987; 15:137-81.
    View in: PubMed
  190. Takeuchi T, Rudd CE, Schlossman SF, Morimoto C. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen. Eur J Immunol. 1987 Jan; 17(1):97-103.
    View in: PubMed
  191. Letvin NL, Zalutsky MR, Lambert JM, Chalifoux LV, Nadler LM, Schlossman SF, Atkins HL. Use of radiolabeled monoclonal anti-B1 antibody for B lymphocyte imaging in rhesus monkeys. Int J Rad Appl Instrum B. 1987; 14(2):99-105.
    View in: PubMed
  192. Schmidt RE, Michon JM, Woronicz J, Schlossman SF, Reinherz EL, Ritz J. Enhancement of natural killer function through activation of the T11 E rosette receptor. J Clin Invest. 1987 Jan; 79(1):305-8.
    View in: PubMed
  193. Blue ML, Craig KA, Daley JF, Levine H, Schlossman SF. Human thymocyte subpopulations: maturational stages defined by the expression of the T3-T cell receptor complex. Acta Haematol. 1987; 78 Suppl 1:43-9.
    View in: PubMed
  194. Schmidt RE, Schlossman SF, Reinherz EL, Ritz J. Activation of natural killer function through the T11/E rosette receptor. Haematol Blood Transfus. 1987; 31:347-50.
    View in: PubMed
  195. Tedder TF, Schmidt RE, Rudd CE, Kornacki MM, Ritz J, Schlossman SF. Function of the LFA-1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes. Eur J Immunol. 1986 Dec; 16(12):1539-43.
    View in: PubMed
  196. Morimoto C, Letvin NL, Rudd CE, Hagan M, Takeuchi T, Schlossman SF. The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells. J Immunol. 1986 Nov 15; 137(10):3247-53.
    View in: PubMed
  197. Letvin NL, Chalifoux LV, Reimann KA, Ritz J, Schlossman SF, Lambert JM. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells. J Clin Invest. 1986 Sep; 78(3):666-73.
    View in: PubMed
  198. Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system. J Immunol. 1986 Aug 15; 137(4):1387-91.
    View in: PubMed
  199. Blue ML, Daley JF, Levine H, Craig KA, Schlossman SF. Biosynthesis and surface expression of T8 by peripheral blood T4+ cells in vitro. J Immunol. 1986 Aug 15; 137(4):1202-7.
    View in: PubMed
  200. Tedder TF, Forsgren A, Boyd AW, Nadler LM, Schlossman SF. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur J Immunol. 1986 Aug; 16(8):881-7.
    View in: PubMed
  201. Blue ML, Daley JF, Levine H, Schlossman SF. Discrete stages of human thymocyte activation and maturation in vitro: correlation between phenotype and function. Eur J Immunol. 1986 Jul; 16(7):771-7.
    View in: PubMed
  202. Rohatiner A, Gelber R, Schlossman SF, Ritz J. Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis. Transplantation. 1986 Jul; 42(1):73-80.
    View in: PubMed
  203. Schmidt RE, Murray C, Daley JF, Schlossman SF, Ritz J. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med. 1986 Jul 1; 164(1):351-6.
    View in: PubMed
  204. Hafler DA, Fallis RJ, Dawson DM, Schlossman SF, Reinherz EL, Weiner HL. Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12. Neurology. 1986 Jun; 36(6):777-84.
    View in: PubMed
  205. Anderson KC, Roach JA, Daley JF, Schlossman SF, Nadler LM. Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti-immunoglobulin stimulated, and in vivo activated B cells. J Immunol. 1986 May 15; 136(10):3612-8.
    View in: PubMed
  206. Boyd AW, Freedman AS, Horowitz JC, Anderson KC, Fisher DC, Rosen KJ, Schlossman SF, Nadler LM. Studies of the in vitro activation and differentiation of human B lymphocytes. II. Optimization of activation by anti-immunoglobulin antibody bound to beads: analysis of the role of autocrine effects on B-cell proliferation and of T-cell help in B-cell differentiation. Cell Immunol. 1986 Apr 15; 99(1):228-40.
    View in: PubMed
  207. Blue ML, Daley JF, Levine H, Schlossman SF. Human thymocyte maturation in vitro: a flow cytometric analysis. Cell Immunol. 1986 Apr 15; 99(1):14-23.
    View in: PubMed
  208. Schmidt RE, Bartley GT, Lee SS, Daley JF, Royer HD, Levine H, Reinherz EL, Schlossman SF, Ritz J. Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity. J Exp Med. 1986 Apr 1; 163(4):812-25.
    View in: PubMed
  209. Seldin DC, Caulfield JP, Hein A, Osathanondh R, Nabel G, Schlossman SF, Stevens RL, Austen KF. Biochemical and phenotypic characterization of human basophilic cells derived from dispersed fetal liver with murine T cell factors. J Immunol. 1986 Mar 15; 136(6):2222-30.
    View in: PubMed
  210. Fox DA, Schlossman SF, Reinherz EL. Regulation of the alternative pathway of T cell activation by anti-T3 monoclonal antibody. J Immunol. 1986 Mar 15; 136(6):1945-50.
    View in: PubMed
  211. Letvin NL, Goldmacher VS, Ritz J, Yetz JM, Schlossman SF, Lambert JM. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. J Clin Invest. 1986 Mar; 77(3):977-84.
    View in: PubMed
  212. Morimoto C, Letvin NL, Distaso JA, Brown HM, Schlossman SF. The cellular basis for the induction of antigen-specific T8 suppressor cells. Eur J Immunol. 1986 Feb; 16(2):198-204.
    View in: PubMed
  213. Blue ML, Schlossman SF. Biology of the T cell. Prog Clin Biol Res. 1986; 224:11-20.
    View in: PubMed
  214. Romain PL, Schlossman SF. The T cell circuit: clinical and biological implications. Adv Intern Med. 1986; 31:1-16.
    View in: PubMed
  215. Schmidt RE, Hercend T, Schlossman SF, Ritz J. Functional surface structures on human natural killer cells. Klin Wochenschr. 1985 Dec 2; 63(23):1189-200.
    View in: PubMed
  216. MacDermott RP, Schmidt RE, Caulfield JP, Hein A, Bartley GT, Ritz J, Schlossman SF, Austen KF, Stevens RL. Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J Exp Med. 1985 Dec 1; 162(6):1771-87.
    View in: PubMed
  217. Blue ML, Daley JF, Levine H, Schlossman SF. Class II major histocompatibility complex molecules regulate the development of the T4+T8- inducer phenotype of cultured human thymocytes. Proc Natl Acad Sci U S A. 1985 Dec; 82(23):8178-82.
    View in: PubMed
  218. Schmidt RE, MacDermott RP, Bartley G, Bertovich M, Amato DA, Austen KF, Schlossman SF, Stevens RL, Ritz J. Specific release of proteoglycans from human natural killer cells during target lysis. Nature. 1985 Nov 21-27; 318(6043):289-91.
    View in: PubMed
  219. Letvin NL, Ritz J, Guida LJ, Yetz JM, Lambert JM, Reinherz EL, Schlossman SF. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool. Blood. 1985 Oct; 66(4):961-6.
    View in: PubMed
  220. Wilson M, Rosen FS, Schlossman SF, Reinherz EL. Ontogeny of human T and B lymphocytes during stressed and normal gestation: phenotypic analysis of umbilical cord lymphocytes from term and preterm infants. Clin Immunol Immunopathol. 1985 Oct; 37(1):1-12.
    View in: PubMed
  221. Hokland P, Ritz J, Schlossman SF, Nadler LM. Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol. 1985 Sep; 135(3):1746-51.
    View in: PubMed
  222. Letvin NL, Morimoto C, Aldrich WR, Schlossman SF. Definition of the T-lymphocyte inducer of suppression in primates using a monoclonal antibody. Cell Immunol. 1985 Sep; 94(2):360-8.
    View in: PubMed
  223. Schmidt RE, Bartley G, Levine H, Schlossman SF, Ritz J. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J Immunol. 1985 Aug; 135(2):1020-5.
    View in: PubMed
  224. Tedder TF, Boyd AW, Freedman AS, Nadler LM, Schlossman SF. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol. 1985 Aug; 135(2):973-9.
    View in: PubMed
  225. Kalish RS, Schlossman SF. The T4 lymphocyte in AIDS. N Engl J Med. 1985 Jul 11; 313(2):112-3.
    View in: PubMed
  226. Schmidt RE, Hercend T, Fox DA, Bensussan A, Bartley G, Daley JF, Schlossman SF, Reinherz EL, Ritz J. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J Immunol. 1985 Jul; 135(1):672-8.
    View in: PubMed
  227. Morimoto C, Letvin NL, Boyd AW, Hagan M, Brown HM, Kornacki MM, Schlossman SF. The isolation and characterization of the human helper inducer T cell subset. J Immunol. 1985 Jun; 134(6):3762-9.
    View in: PubMed
  228. Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL, Weiner HL. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med. 1985 May 30; 312(22):1405-11.
    View in: PubMed
  229. Blue ML, Daley JF, Levine H, Schlossman SF. Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol. 1985 Apr; 134(4):2281-6.
    View in: PubMed
  230. Smolen JS, Morimoto C, Steinberg AD, Wolf A, Schlossman SF, Steinberg RT, Penner E, Reinherz E, Reichlin M, Chused TM. Systemic lupus erythematosus: delineation of subpopulations by clinical, serologic, and T cell subset analysis. Am J Med Sci. 1985 Apr; 289(4):139-47.
    View in: PubMed
  231. Boyd AW, Fisher DC, Fox DA, Schlossman SF, Nadler LM. Structural and functional characterization of IL 2 receptors on activated human B cells. J Immunol. 1985 Apr; 134(4):2387-92.
    View in: PubMed
  232. Freedman AS, Boyd AW, Anderson KC, Fisher DC, Schlossman SF, Nadler LM. B5, a new B cell-restricted activation antigen. J Immunol. 1985 Apr; 134(4):2228-35.
    View in: PubMed
  233. Morimoto C, Matsuyama T, Oshige C, Tanaka H, Hercend T, Reinherz EL, Schlossman SF. Functional and phenotypic studies of Japanese adult T cell leukemia cells. J Clin Invest. 1985 Mar; 75(3):836-43.
    View in: PubMed
  234. Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF. The isolation and characterization of the human suppressor inducer T cell subset. J Immunol. 1985 Mar; 134(3):1508-15.
    View in: PubMed
  235. Hercend T, Griffin JD, Bensussan A, Schmidt RE, Edson MA, Brennan A, Murray C, Daley JF, Schlossman SF, Ritz J. Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest. 1985 Mar; 75(3):932-43.
    View in: PubMed
  236. Freedman AS, Boyd AW, Anderson KC, Fisher DC, Pinkus GS, Schlossman SF, Nadler LM. Immunologic heterogeneity of diffuse large cell lymphoma. Blood. 1985 Mar; 65(3):630-7.
    View in: PubMed
  237. Boyd AW, Anderson KC, Freedman AS, Fisher DC, Slaughenhoupt B, Schlossman SF, Nadler LM. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J Immunol. 1985 Mar; 134(3):1516-23.
    View in: PubMed
  238. Anderson KC, Boyd AW, Fisher DC, Leslie D, Schlossman SF, Nadler LM. Hairy cell leukemia: a tumor of pre-plasma cells. Blood. 1985 Mar; 65(3):620-9.
    View in: PubMed
  239. Anderson KC, Boyd AW, Fisher DC, Slaughenhoupt B, Groopman JE, O'Hara CJ, Daley JF, Schlossman SF, Nadler LM. Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets. J Immunol. 1985 Feb; 134(2):820-7.
    View in: PubMed
  240. Acuto O, Fabbi M, Schlossman SF, Reinherz EL. Molecular analysis of the human T-cell-antigen receptor. Biochem Soc Trans. 1985 Feb; 13(1):6-10.
    View in: PubMed
  241. Shkolnik T, Schlossman SF, Griffin JD. Acute undifferentiated leukemia: induction of partial differentiation by phorbol ester. Leuk Res. 1985; 9(1):11-7.
    View in: PubMed
  242. Fox DA, Hussey RE, Fitzgerald KA, Bensussan A, Daley JF, Schlossman SF, Reinherz EL. Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. J Immunol. 1985 Jan; 134(1):330-5.
    View in: PubMed
  243. Schlossman SF, Benacerraf B. Dr. Elvin Kabat: an appreciation of his scientific contributions. Mol Immunol. 1984 Nov; 21(11):1009-10.
    View in: PubMed
  244. Romain PL, Schlossman SF. Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures. J Clin Invest. 1984 Nov; 74(5):1559-65.
    View in: PubMed
  245. Reinherz EL, Acuto O, Fabbi M, Bensussan A, Milanese C, Royer HD, Meuer SC, Schlossman SF. Clonotypic surface structure on human T lymphocytes: functional and biochemical analysis of the antigen receptor complex. Immunol Rev. 1984 Oct; 81:95-129.
    View in: PubMed
  246. Griffin JD, Meuer SC, Schlossman SF, Reinherz EL. T cell regulation of myelopoiesis: analysis at a clonal level. J Immunol. 1984 Oct; 133(4):1863-8.
    View in: PubMed
  247. Morimoto C, Distaso JA, Cheney JJ, Reinherz EL, Schlossman SF. Cellular interaction between subsets of T8 population for maximal suppression of antigen-specific antibody response. Cell Immunol. 1984 Oct 1; 88(1):75-84.
    View in: PubMed
  248. Fox DA, Hussey RE, Fitzgerald KA, Acuto O, Poole C, Palley L, Daley JF, Schlossman SF, Reinherz EL. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol. 1984 Sep; 133(3):1250-6.
    View in: PubMed
  249. Hercend T, Schmidt R, Brennan A, Edson MA, Reinherz EL, Schlossman SF, Ritz J. Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines. Eur J Immunol. 1984 Sep; 14(9):844-52.
    View in: PubMed
  250. Hokland P, Nadler LM, Griffin JD, Schlossman SF, Ritz J. Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood. 1984 Sep; 64(3):662-6.
    View in: PubMed
  251. Rimm IJ, Schlossman SF, Reinherz EL. Natural killer-like activity mediated by activated T lymphocytes. Cell Immunol. 1984 Sep; 87(2):327-39.
    View in: PubMed
  252. Romain PL, Schlossman SF, Reinherz EL. Surface molecules involved in self-recognition and T cell activation in the autologous mixed lymphocyte reaction. J Immunol. 1984 Sep; 133(3):1093-100.
    View in: PubMed
  253. Nadler LM, Takvorian T, Botnick L, Bast RC, Finberg R, Hellman S, Canellos GP, Schlossman SF. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet. 1984 Aug 25; 2(8400):427-31.
    View in: PubMed
  254. Hercend T, Meuer S, Brennan A, Edson MA, Acuto O, Reinherz EL, Schlossman SF, Ritz J. Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure. Cell Immunol. 1984 Jul; 86(2):381-92.
    View in: PubMed
  255. Biondi A, Roach JA, Schlossman SF, Todd RF. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines. J Immunol. 1984 Jul; 133(1):281-5.
    View in: PubMed
  256. Acuto O, Fabbi M, Smart J, Poole CB, Protentis J, Royer HD, Schlossman SF, Reinherz EL. Purification and NH2-terminal amino acid sequencing of the beta subunit of a human T-cell antigen receptor. Proc Natl Acad Sci U S A. 1984 Jun; 81(12):3851-5.
    View in: PubMed
  257. Anderson KC, Bates MP, Slaughenhoupt B, Schlossman SF, Nadler LM. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol. 1984 Jun; 132(6):3172-9.
    View in: PubMed
  258. Anderson KC, Bates MP, Slaughenhoupt BL, Pinkus GS, Schlossman SF, Nadler LM. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun; 63(6):1424-33.
    View in: PubMed
  259. Todd RF, Meuer SC, Romain PL, Schlossman SF. A monoclonal antibody that blocks class II histocompatibility-related immune interactions. Hum Immunol. 1984 May; 10(1):23-40.
    View in: PubMed
  260. Brahn E, Helfgott SM, Belli JA, Anderson RJ, Reinherz EL, Schlossman SF, Austen KF, Trentham DE. Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup. Arthritis Rheum. 1984 May; 27(5):481-8.
    View in: PubMed
  261. Rimm IJ, Bhan AK, Schneeberger EE, Schlossman SF, Reinherz EL. Characterization of human thymic epithelial cells grown in serum-free medium. Clin Immunol Immunopathol. 1984 Apr; 31(1):56-64.
    View in: PubMed
  262. Chalifoux LV, Schlossman SF, Letvin NL. Delineation of lymphocyte subsets in lymph nodes of nonhuman primates. Clin Immunol Immunopathol. 1984 Apr; 31(1):96-101.
    View in: PubMed
  263. Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA, Hodgdon JC, Protentis JP, Schlossman SF, Reinherz EL. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell. 1984 Apr; 36(4):897-906.
    View in: PubMed
  264. Griffin JD, Sullivan R, Beveridge RP, Larcom P, Schlossman SF. Induction of proliferation of purified human myeloid progenitor cells: a rapid assay for granulocyte colony-stimulating factors. Blood. 1984 Apr; 63(4):904-11.
    View in: PubMed
  265. Meuer SC, Hussey RE, Cantrell DA, Hodgdon JC, Schlossman SF, Smith KA, Reinherz EL. Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A. 1984 Mar; 81(5):1509-13.
    View in: PubMed
  266. Letvin NL, Aldrich WR, Thorley-Lawson DA, Schlossman SF, Nadler LM. Surface antigen changes during B-lymphocyte activation in primates. Cell Immunol. 1984 Mar; 84(1):163-70.
    View in: PubMed
  267. Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest. 1984 Mar; 73(3):689-700.
    View in: PubMed
  268. Schwaber JF, Posner MR, Schlossman SF, Lazarus H. Human-human hybrids secreting pneumococcal antibodies. Hum Immunol. 1984 Mar; 9(3):137-43.
    View in: PubMed
  269. Borel Y, Morimoto C, Cairns L, Mantzouranis E, Strelkauskas AJ, Schlossman SF. Anti-T cell antibody in juvenile rheumatoid arthritis. J Rheumatol. 1984 Feb; 11(1):56-61.
    View in: PubMed
  270. Bensussan A, Meuer SC, Schlossman SF, Reinherz EL. Delineation of an immunoregulatory amplifier population recognizing autologous Ia molecules. Analysis with human T cell clones. J Exp Med. 1984 Feb 1; 159(2):559-76.
    View in: PubMed
  271. Palley LS, Schlossman SF, Letvin NL. Common tree shrews and primates share leukocyte membrane antigens. J Med Primatol. 1984; 13(2):67-71.
    View in: PubMed
  272. Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk Res. 1984; 8(4):521-34.
    View in: PubMed
  273. Romain PL, Schlossman SF. Use of anti-Fab columns for the isolation of human lymphocyte populations. Methods Enzymol. 1984; 108:148-53.
    View in: PubMed
  274. Romain PL, Morimoto C, Daley JF, Palley LS, Reinherz EL, Schlossman SF. Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction. Clin Immunol Immunopathol. 1984 Jan; 30(1):117-28.
    View in: PubMed
  275. Romain PL, Acuto O, Schlossman SF. Identification and characterization of human T lymphocyte antigens. Methods Enzymol. 1984; 108:624-42.
    View in: PubMed
  276. Romain PL, Schlossman SF. The human T-cell circuit. Uremia Invest. 1984-1985; 8(3-4):151-6.
    View in: PubMed
  277. Meuer SC, Acuto O, Hercend T, Schlossman SF, Reinherz EL. The human T-cell receptor. Annu Rev Immunol. 1984; 2:23-50.
    View in: PubMed
  278. Schlossman SF. Dissection of the T-cell circuit with monoclonal antibodies. Med Oncol Tumor Pharmacother. 1984; 1(4):247-53.
    View in: PubMed
  279. Schlossman SF, Reinherz EL. Human T-cell subsets in health and disease. Springer Semin Immunopathol. 1984; 7(1):9-18.
    View in: PubMed
  280. Meuer SC, Cooper DA, Hodgdon JC, Hussey RE, Fitzgerald KA, Schlossman SF, Reinherz EL. Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. Science. 1983 Dec 16; 222(4629):1239-42.
    View in: PubMed
  281. Kirkman RL, Araujo JL, Busch GJ, Carpenter CB, Milford EL, Reinherz EL, Schlossman SF, Strom TB, Tilney NL. Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. Transplantation. 1983 Dec; 36(6):620-6.
    View in: PubMed
  282. Griffin JD, Larcom P, Schlossman SF. Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell properties. Blood. 1983 Dec; 62(6):1300-3.
    View in: PubMed
  283. Hercend T, Meuer S, Brennan A, Edson MA, Acuto O, Reinherz EL, Schlossman SF, Ritz J. Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function. J Exp Med. 1983 Nov 1; 158(5):1547-60.
    View in: PubMed
  284. Hauser SL, Bhan AK, Gilles FH, Hoban CJ, Reinherz EL, Schlossman SF, Weiner HL. Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen. J Neuroimmunol. 1983 Oct; 5(2):197-205.
    View in: PubMed
  285. Morimoto C, Masuho Y, Borel Y, Steinberg AD, Schlossman SF. Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate. J Immunol. 1983 Oct; 131(4):1762-4.
    View in: PubMed
  286. Acuto O, Meuer SC, Hodgdon JC, Schlossman SF, Reinherz EL. Peptide variability exists within alpha and beta subunits of the T cell receptor for antigen. J Exp Med. 1983 Oct 1; 158(4):1368-73.
    View in: PubMed
  287. Pesando JM, Tomaselli KJ, Lazarus H, Schlossman SF. Distribution and modulation of a human leukemia-associated antigen (CALLA). J Immunol. 1983 Oct; 131(4):2038-45.
    View in: PubMed
  288. Acuto O, Hussey RE, Fitzgerald KA, Protentis JP, Meuer SC, Schlossman SF, Reinherz EL. The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors. Cell. 1983 Oct; 34(3):717-26.
    View in: PubMed
  289. Meuer SC, Cooper DA, Hodgdon JC, Hussey RE, Morimoto C, Schlossman SF, Reinherz EL. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. J Immunol. 1983 Sep; 131(3):1167-72.
    View in: PubMed
  290. Morimoto C, Reinherz EL, Todd RF, Distaso JA, Schlossman SF. Generation of antigen-specific suppressor cells in vitro in man. J Immunol. 1983 Sep; 131(3):1209-13.
    View in: PubMed
  291. Meuer SC, Hodgdon JC, Hussey RE, Protentis JP, Schlossman SF, Reinherz EL. Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med. 1983 Sep 1; 158(3):988-93.
    View in: PubMed
  292. Griffin JD, Mayer RJ, Weinstein HJ, Rosenthal DS, Coral FS, Beveridge RP, Schlossman SF. Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes. Blood. 1983 Sep; 62(3):557-63.
    View in: PubMed
  293. Nadler LA, Anderson KC, Schlossman SF. Human T and B cell derived malignancies. Rinsho Ketsueki. 1983 Aug; 24(8):987-95.
    View in: PubMed
  294. Anderson KC, Griffin JD, Bates MP, Slaughenhoupt BL, Schlossman SF, Nadler LM. Isolation and characterization of human B lymphocyte enriched populations. I. Purification of B cells by immune rosette depletion. J Immunol Methods. 1983 Jul 29; 61(3):283-92.
    View in: PubMed
  295. Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF, Schlossman SF. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol. 1983 Jul; 131(1):244-50.
    View in: PubMed
  296. Bast RC, Reinherz EL, Maver C, Lavin P, Schlossman SF. Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes. Clin Immunol Immunopathol. 1983 Jul; 28(1):101-14.
    View in: PubMed
  297. Meuer SC, Hodgdon JC, Cooper DA, Hussey RE, Fitzgerald KA, Schlossman SF, Reinherz EL. Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. J Immunol. 1983 Jul; 131(1):186-90.
    View in: PubMed
  298. Arnaout MA, Todd RF, Dana N, Melamed J, Schlossman SF, Colten HR. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest. 1983 Jul; 72(1):171-9.
    View in: PubMed
  299. Reinherz EL, Meuer SC, Fitzgerald KA, Hussey RE, Hodgdon JC, Acuto O, Schlossman SF. Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures. Proc Natl Acad Sci U S A. 1983 Jul; 80(13):4104-8.
    View in: PubMed
  300. Rosenthal P, Rimm IJ, Umiel T, Griffin JD, Osathanondh R, Schlossman SF, Nadler LM. Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. J Immunol. 1983 Jul; 131(1):232-7.
    View in: PubMed
  301. Meuer SC, Acuto O, Hussey RE, Hodgdon JC, Fitzgerald KA, Schlossman SF, Reinherz EL. Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor. Nature. 1983 Jun 30; 303(5920):808-10.
    View in: PubMed
  302. Griffin JD, Hercend T, Beveridge R, Schlossman SF. Characterization of an antigen expressed by human natural killer cells. J Immunol. 1983 Jun; 130(6):2947-51.
    View in: PubMed
  303. Hokland M, Hokland P, Heron I, Schlossman SF. Selective effects of alpha interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol. 1983 Jun; 17(6):559-67.
    View in: PubMed
  304. Morimoto C, Steinberg AD, Schlossman SF, Borel Y. In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus. J Clin Invest. 1983 May; 71(5):1402-9.
    View in: PubMed
  305. Letvin NL, Eaton KA, Aldrich WR, Sehgal PK, Blake BJ, Schlossman SF, King NW, Hunt RD. Acquired immunodeficiency syndrome in a colony of macaque monkeys. Proc Natl Acad Sci U S A. 1983 May; 80(9):2718-22.
    View in: PubMed
  306. Hauser SL, Reinherz EL, Hoban CJ, Schlossman SF, Weiner HL. CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell subsets. Neurology. 1983 May; 33(5):575-9.
    View in: PubMed
  307. Griffin JD, Ritz J, Beveridge RP, Lipton JM, Daley JF, Schlossman SF. Expression of MY7 antigen on myeloid precursor cells. Int J Cell Cloning. 1983 Apr; 1(1):33-48.
    View in: PubMed
  308. Posner MR, Reinherz E, Lane H, Mauch P, Hellman S, Schlossman SF. Circulating lymphocyte populations in Hodgkin's disease after mantle and paraaortic irradiation. Blood. 1983 Apr; 61(4):705-8.
    View in: PubMed
  309. Letvin NL, King NW, Reinherz EL, Hunt RD, Lane H, Schlossman SF. T lymphocyte surface antigens in primates. Eur J Immunol. 1983 Apr; 13(4):345-7.
    View in: PubMed
  310. Klein G, Ehlin-Henriksson B, Schlossman SF. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains. J Immunol. 1983 Apr; 130(4):1985-9.
    View in: PubMed
  311. Hauser SL, Reinherz EL, Hoban CJ, Schlossman SF, Weiner HL. Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period. Ann Neurol. 1983 Apr; 13(4):418-25.
    View in: PubMed
  312. Griffin JD, Tantravahi R, Canellos GP, Wisch JS, Reinherz EL, Sherwood G, Beveridge RP, Daley JF, Lane H, Schlossman SF. T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood. 1983 Apr; 61(4):640-4.
    View in: PubMed
  313. Anderson KC, Park EK, Bates MP, Leonard RC, Hardy R, Schlossman SF, Nadler LM. Antigens on human plasma cells identified by monoclonal antibodies. J Immunol. 1983 Mar; 130(3):1132-8.
    View in: PubMed
  314. Bast RC, Ritz J, Lipton JM, Feeney M, Sallan SE, Nathan DG, Schlossman SF. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res. 1983 Mar; 43(3):1389-94.
    View in: PubMed
  315. Roder JC, Todd RF, Rubin P, Haliotis T, Helfand SL, Werkmeister J, Pross HF, Boxer LA, Schlossman SF, Fauci AS. The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment. Clin Exp Immunol. 1983 Feb; 51(2):359-68.
    View in: PubMed
  316. Meuer SC, Fitzgerald KA, Hussey RE, Hodgdon JC, Schlossman SF, Reinherz EL. Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. J Exp Med. 1983 Feb 1; 157(2):705-19.
    View in: PubMed
  317. Letvin NL, Todd RF, Palley LS, Schlossman SF, Griffin JD. Conservation of myeloid surface antigens on primate granulocytes. Blood. 1983 Feb; 61(2):408-10.
    View in: PubMed
  318. Hercend T, Reinherz EL, Meuer S, Schlossman SF, Ritz J. Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature. 1983 Jan 13; 301(5896):158-60.
    View in: PubMed
  319. Hokland P, Rosenthal P, Griffin JD, Nadler LM, Daley J, Hokland M, Schlossman SF, Ritz J. Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med. 1983 Jan 1; 157(1):114-29.
    View in: PubMed
  320. Todd RF, Leeman EL, Daley JF, Schlossman SF. Mo2: functional properties of antigen-bearing cells. Clin Immunol Immunopathol. 1983 Jan; 26(1):118-25.
    View in: PubMed
  321. Griffin JD, Todd RF, Ritz J, Nadler LM, Canellos GP, Rosenthal D, Gallivan M, Beveridge RP, Weinstein H, Karp D, Schlossman SF. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood. 1983 Jan; 61(1):85-91.
    View in: PubMed
  322. Posner MR, Schlossman SF, Lazarus H. Novel approach to construction of human "myeloma analogues" for production of human monoclonal antibodies. Hybridoma. 1983; 2(4):369-81.
    View in: PubMed
  323. Carpenter CB, Milford EL, Reinherz EL, Schlossman SF, Tilney NL, Strom TB, Kirkman RL, Busch GJ, Araujo JL. Monoclonal anti-T12 antibody as therapy for renal allograft rejection. Trans Assoc Am Physicians. 1983; 96:84-92.
    View in: PubMed
  324. Griffin JD, Beveridge RP, Schlossman SF. Effect of phorbol ester on differentiation of human myeloid colony forming cells (CFU-C). Leuk Res. 1983; 7(1):43-9.
    View in: PubMed
  325. Ritz J, Sallan SE, Bast RC, Lipton JM, Nathan DG, Schlossman SF. In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia. Haematol Blood Transfus. 1983; 28:117-23.
    View in: PubMed
  326. Reinherz EL, Meuer SC, Schlossman SF. The human T cell receptor: analysis with cytotoxic T cell clones. Immunol Rev. 1983; 74:83-112.
    View in: PubMed
  327. Schlossman SF. The human T-cell circuit--biologic and clinical implications. Harvey Lect. 1983-1984; 79:31-49.
    View in: PubMed
  328. Morimoto C, Reinherz EL, Borel Y, Schlossman SF. Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies. J Immunol. 1983 Jan; 130(1):157-61.
    View in: PubMed
  329. Hauser SL, Ropper AH, Perlo VP, Reinherz EL, Schlossman SF, Weiner HL. T-cell subsets in human autoimmune diseases. Neurology. 1982 Nov; 32(11):1320-1.
    View in: PubMed
  330. Hurley CK, Shaw S, Nadler L, Schlossman S, Capra JD. Alpha and beta chains of SB and DR antigens are structurally distinct. J Exp Med. 1982 Nov 1; 156(5):1557-62.
    View in: PubMed
  331. Meuer SC, Hussey RE, Hodgdon JC, Hercend T, Schlossman SF, Reinherz EL. Surface structures involved in target recognition by human cytotoxic T lymphocytes. Science. 1982 Oct 29; 218(4571):471-3.
    View in: PubMed
  332. Reinherz EL, Geha R, Rappeport JM, Wilson M, Penta AC, Hussey RE, Fitzgerald KA, Daley JF, Levine H, Rosen FS, Schlossman SF. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci U S A. 1982 Oct; 79(19):6047-51.
    View in: PubMed
  333. Reinherz EL, Meuer S, Fitzgerald KA, Hussey RE, Levine H, Schlossman SF. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell. 1982 Oct; 30(3):735-43.
    View in: PubMed
  334. Bekoff MC, Levine H, Schlossman SF. T cell and IR gene regulation of expression of a cross-reactive idiotype. J Immunol. 1982 Sep; 129(3):1173-80.
    View in: PubMed
  335. Meuer SC, Hussey RE, Penta AC, Fitzgerald KA, Stadler BM, Schlossman SF, Reinherz EL. Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes. J Immunol. 1982 Sep; 129(3):1076-9.
    View in: PubMed
  336. Umiel T, Daley JF, Bhan AK, Levey RH, Schlossman SF, Reinherz EL. Acquisition of immune competence by a subset of human cortical thymocytes expressing mature T cell antigens. J Immunol. 1982 Sep; 129(3):1054-60.
    View in: PubMed
  337. Shaw S, DeMars R, Schlossman SF, Smith PL, Lampson LA, Nadler LM. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure. J Exp Med. 1982 Sep 1; 156(3):731-43.
    View in: PubMed
  338. Hercend T, Meuer S, Reinherz EL, Schlossman SF, Ritz J. Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood. J Immunol. 1982 Sep; 129(3):1299-305.
    View in: PubMed
  339. Nadler LM, Ritz J, Bates MP, Park EK, Anderson KC, Sallan SE, Schlossman SF. Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. J Clin Invest. 1982 Aug; 70(2):433-42.
    View in: PubMed
  340. Ritz J, Sallan SE, Bast RC, Lipton JM, Clavell LA, Feeney M, Hercend T, Nathan DG, Schlossman SF. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet. 1982 Jul 10; 2(8289):60-3.
    View in: PubMed
  341. Griffin JD, Beveridge RP, Schlossman SF. Isolation of myeloid progenitor cells from peripheral blood of chronic myelogenous leukemia patients. Blood. 1982 Jul; 60(1):30-7.
    View in: PubMed
  342. Meuer SC, Schlossman SF, Reinherz EL. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A. 1982 Jul; 79(14):4395-9.
    View in: PubMed
  343. Campos-Neto A, Levine H, Schlossman SF. Immune response gene control of antibody specificity. Cell Immunol. 1982 May 1; 69(1):128-37.
    View in: PubMed
  344. Wallace JI, Coral FS, Rimm IR, Lane H, Levine H, Reinherz EL, Schlossman SF, Sonnabend J. T-cell ratios in homosexuals. Lancet. 1982 Apr 17; 1(8277):908.
    View in: PubMed
  345. Todd RF, Schlossman SF. Analysis of antigenic determinants on human monocytes and macrophages. Blood. 1982 Apr; 59(4):775-86.
    View in: PubMed
  346. Morimoto C, Distaso JA, Borel Y, Schlossman SF, Reinherz EL. Communicative interactions between subpopulations of human T lymphocytes required for generation of suppressor effector function in a primary antibody response. J Immunol. 1982 Apr; 128(4):1645-50.
    View in: PubMed
  347. Reinherz EL, Schlossman SF. The characterization and function of human immunoregulatory T lymphocyte subsets. Pharmacol Rev. 1982 Mar; 34(1):17-22.
    View in: PubMed
  348. Bhan AK, Dienstag JL, Wands JR, Schlossman SF, Reinherz EL. Alterations of T-cell subsets in primary biliary cirrhosis. Clin Exp Immunol. 1982 Feb; 47(2):351-8.
    View in: PubMed
  349. Poppema S, Bhan AK, Reinherz EL, Posner MR, Schlossman SF. In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood. 1982 Feb; 59(2):226-32.
    View in: PubMed
  350. Morimoto C, Reinherz EL, Nadler LM, Distaso JA, Steinberg AD, Schlossman SF. Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus. Clin Immunol Immunopathol. 1982 Feb; 22(2):270-8.
    View in: PubMed
  351. Raso V, Ritz J, Basala M, Schlossman SF. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Cancer Res. 1982 Feb; 42(2):457-64.
    View in: PubMed
  352. Posner MR, Antoniou D, Griffin J, Schlossman SF, Lazarus H. An enzyme-linked immunosorbent assay (ELISA) for the detection of monoclonal antibodies to cell surface antigens on viable cells. J Immunol Methods. 1982; 48(1):23-31.
    View in: PubMed
  353. Reinherz EL, Morimoto C, Fitzgerald KA, Hussey RE, Daley JF, Schlossman SF. Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol. 1982 Jan; 128(1):463-8.
    View in: PubMed
  354. Todd RF, Schlossman SF. Antigenic markers on human monocytes and macrophages. Adv Exp Med Biol. 1982; 155:409-21.
    View in: PubMed
  355. Ritz J, Schlossman SF. Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood. 1982 Jan; 59(1):1-11.
    View in: PubMed
  356. Todd RF, Van Agthoven A, Schlossman SF, Terhorst C. Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma. 1982; 1(3):329-37.
    View in: PubMed
  357. Reinherz EL, Hussey RE, Fitzgerald K, Snow P, Terhorst C, Schlossman SF. Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes. Nature. 1981 Nov 12; 294(5837):168-70.
    View in: PubMed
  358. Hercend T, Ritz J, Schlossman SF, Reinherz EL. Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. Hum Immunol. 1981 Nov; 3(3):247-59.
    View in: PubMed
  359. Ritz J, Pesando JM, Notis-McConarty J, Clavell LA, Sallan SE, Schlossman SF. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 2):4771-5.
    View in: PubMed
  360. Lyons CR, Lipscomb MF, Schlossman SF, Tucker TF, Uhr JW. Biochemical characterization of Ia alloantigens in guinea pigs. I. Synthesis of Ia antigens by subsets enriched for B cells, T cells, or macrophages. J Immunol. 1981 Nov; 127(5):1879-85.
    View in: PubMed
  361. Reinherz EL, Penta AC, Hussey RE, Schlossman SF. A rapid method for separating functionally intact human T lymphocytes with monoclonal antibodies. Clin Immunol Immunopathol. 1981 Nov; 21(2):257-66.
    View in: PubMed
  362. Reinherz EL, Schlossman SF. Derivation of human T-cell leukemias. Cancer Res. 1981 Nov; 41(11 Pt 2):4767-70.
    View in: PubMed
  363. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest. 1981 Oct; 68(4):932-41.
    View in: PubMed
  364. Hercend T, Nadler LM, Pesando JM, Reinherz EL, Schlossman SF, Ritz J. Expression of a 26,000-dalton glycoprotein on activated human T cells. Cell Immunol. 1981 Oct; 64(1):192-9.
    View in: PubMed
  365. Rimm IJ, Schlossman SF, Reinherz EL. Antibody-dependent cellular cytotoxicity and natural-killer-like activity are mediated by subsets of activated T cells. Clin Immunol Immunopathol. 1981 Oct; 21(1):134-40.
    View in: PubMed
  366. Posner MR, Reinherz EL, Breard J, Nadler LM, Rosenthal DS, Schlossman SF. Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease. Cancer. 1981 Sep 1; 48(5):1170-6.
    View in: PubMed
  367. Bhan AK, Nadler LM, Stashenko P, McCluskey RT, Schlossman SF. Stages of B cell differentiation in human lymphoid tissue. J Exp Med. 1981 Sep 1; 154(3):737-49.
    View in: PubMed
  368. Geha RS, Reinherz E, Leung D, McKee KT, Schlossman S, Rosen FS. Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J Clin Invest. 1981 Sep; 68(3):783-91.
    View in: PubMed
  369. Reinherz EL, Cooper MD, Schlossman SF, Rosen FS. Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders. J Clin Invest. 1981 Sep; 68(3):699-705.
    View in: PubMed
  370. Ritz J, Nadler LM, Bhan AK, Notis-McConarty J, Pesando JM, Schlossman SF. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood. 1981 Sep; 58(3):648-52.
    View in: PubMed
  371. Morimoto C, Todd RF, Distaso JA, Schlossman SF. The role of the macrophage in in vitro primary anti-DNP antibody production in man. J Immunol. 1981 Sep; 127(3):1137-41.
    View in: PubMed
  372. Fischer A, Durandy A, Virelizier JL, De Saint Basile G, Lagrue A, Reinherz E, Schlossman S, Griscelli C. Severe combined immunodeficiency with quantitatively normal but abnormally differentiated T lymphocytes. J Pediatr. 1981 Aug; 99(2):261-4.
    View in: PubMed
  373. Pesando JM, Nadler LM, Lazarus H, Tomaselli KJ, Stashenko P, Ritz J, Levine H, Yunis EJ, Schlossman SF. Human cell lines express multiple populations of Ia-like molecules. Hum Immunol. 1981 Aug; 3(1):67-76.
    View in: PubMed
  374. Morimoto C, Reinherz EL, Schlossman SF. Primary in vitro anti-KLH antibody formation by peripheral blood lymphocytes in man: detection with a radioimmunoassay. J Immunol. 1981 Aug; 127(2):514-7.
    View in: PubMed
  375. Morimoto C, Reinherz EL, Schlossman SF. Regulation of in vitro primary anti-DNP antibody production by functional subsets of T lymphocytes in man. J Immunol. 1981 Jul; 127(1):69-73.
    View in: PubMed
  376. Ritz J, Pesando JM, Sallan SE, Clavell LA, Notis-McConarty J, Rosenthal P, Schlossman SF. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood. 1981 Jul; 58(1):141-52.
    View in: PubMed
  377. Stashenko P, Nadler LM, Hardy R, Schlossman SF. Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci U S A. 1981 Jun; 78(6):3848-52.
    View in: PubMed
  378. Bernard A, Boumsell L, Reinherz EL, Nadler LM, Ritz J, Coppin H, Richard Y, Valensi F, Dausset J, Flandrin G, Lemerle J, Schlossman SF. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood. 1981 Jun; 57(6):1105-10.
    View in: PubMed
  379. Nadler LM, Stashenko P, Hardy R, van Agthoven A, Terhorst C, Schlossman SF. Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol. 1981 May; 126(5):1941-7.
    View in: PubMed
  380. Nadler LM, Stashenko P, Hardy R, Tomaselli KJ, Yunis EJ, Schlossman SF, Pesando JM. Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region. Nature. 1981 Apr 16; 290(5807):591-3.
    View in: PubMed
  381. Reinherz EL, Geha R, Wohl ME, Morimoto C, Rosen FS, Schlossman SF. Immunodeficiency associated with loss of T4+ inducer T-cell function. N Engl J Med. 1981 Apr 2; 304(14):811-6.
    View in: PubMed
  382. Todd RF, Nadler LM, Schlossman SF. Antigens on human monocytes identified by monoclonal antibodies. J Immunol. 1981 Apr; 126(4):1435-42.
    View in: PubMed
  383. Boumsell L, Bernard A, Reinherz EL, Nadler LM, Ritz J, Coppin H, Richard Y, Dubertret L, Valensi F, Degos L, Lemerle J, Flandrin G, Dausset J, Schlossman SF. Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood. 1981 Mar; 57(3):526-30.
    View in: PubMed
  384. Morimoto C, Reinherz EL, Borel Y, Mantzouranis E, Steinberg AD, Schlossman SF. Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis. J Clin Invest. 1981 Mar; 67(3):753-61.
    View in: PubMed
  385. Terhorst C, van Agthoven A, LeClair K, Snow P, Reinherz E, Schlossman S. Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10. Cell. 1981 Mar; 23(3):771-80.
    View in: PubMed
  386. Pesando JM, Ritz J, Lazarus H, Tomaselli KJ, Schlossman SF. Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody. J Immunol. 1981 Feb; 126(2):540-4.
    View in: PubMed
  387. Nadler LM, Stashenko P, Hardy R, Pesando JM, Yunis EJ, Schlossman SF. Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. Hum Immunol. 1981 Feb; 2(1):77-90.
    View in: PubMed
  388. Poppema S, Bhan AK, Reinherz EL, McCluskey RT, Schlossman SF. Distribution of T cell subsets in human lymph nodes. J Exp Med. 1981 Jan 1; 153(1):30-41.
    View in: PubMed
  389. Nadler LM, Ritz J, Griffin JD, Todd RF, Reinherz EL, Schlossman SF. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. Prog Hematol. 1981; 12:187-225.
    View in: PubMed
  390. Breard J, Reinherz EL, O'Brien C, Schlossman SF. Delineation of an effector population responsible for natural killing and antibody-dependent cellular cytotoxicity in man. Clin Immunol Immunopathol. 1981 Jan; 18(1):145-50.
    View in: PubMed
  391. Schlossman SF. Characterization and function of human lymphocyte subsets. Prog Clin Biol Res. 1981; 58:3-6.
    View in: PubMed
  392. Nadler LM, Ritz J, Hardy R, Pesando JM, Schlossman SF, Stashenko P. A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest. 1981 Jan; 67(1):134-40.
    View in: PubMed
  393. Greaves MF, Robinson JB, Delia D, Ritz J, Schlossman S, Sieff C, Goldstein G, Kung P, Bollum FJ, Edwards PA. Comparative antigenic phenotypes of normal and leukemic hemopoietic precursor cells analysed with a "library" of monoclonal antibodies. Haematol Blood Transfus. 1981; 26:296-304.
    View in: PubMed
  394. van Agthoven A, Terhorst C, Reinherz E, Schlossman S. Characterization of T cell surface glycoproteins T 1 and T 3 present on all human peripheral T lymphocytes and functionally mature thymocytes. Eur J Immunol. 1981 Jan; 11(1):18-21.
    View in: PubMed
  395. Reinherz EL, Morimoto C, Penta AC, Schlossman SF. Subpopulations of the T4+ inducer T cell subset in man: evidence for an amplifier population preferentially expressing Ia antigen upon activation. J Immunol. 1981 Jan; 126(1):67-70.
    View in: PubMed
  396. Todd RF, Griffin JD, Ritz J, Nadler LM, Abrams T, Schlossman SF. Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester. Leuk Res. 1981; 5(6):491-5.
    View in: PubMed
  397. Todd RF, Schlossman SF. Human macrophage--lymphocyte interaction in proliferation to soluble antigen. II. Characterization of lymphocyte binding to antigen-pulsed macrophage monolayers. Cell Immunol. 1980 Nov; 56(1):205-16.
    View in: PubMed
  398. Morimoto C, Reinherz EL, Schlossman SF, Schur PH, Mills JA, Steinberg AD. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest. 1980 Nov; 66(5):1171-4.
    View in: PubMed
  399. Callery RT, Strelkauskas AJ, Yanovich S, Marks S, Rosenthal D, Schlossman SF. Functional abnormalities associated with T lymphocytes from patients with chronic lymphocytic leukemia. Clin Immunol Immunopathol. 1980 Nov; 17(3):451-8.
    View in: PubMed
  400. Stashenko P, Nadler LM, Hardy R, Schlossman SF. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct; 125(4):1678-85.
    View in: PubMed
  401. Reinherz EL, Hussey RE, Schlossman SF. A monoclonal antibody blocking human T cell function. Eur J Immunol. 1980 Oct; 10(10):758-62.
    View in: PubMed
  402. Ritz J, Pesando JM, Notis-McConarty J, Schlossman SF. Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro. J Immunol. 1980 Oct; 125(4):1506-14.
    View in: PubMed
  403. Bhan AK, Reinherz EL, Poppema S, McCluskey RT, Schlossman SF. Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med. 1980 Oct 1; 152(4):771-82.
    View in: PubMed
  404. Todd RF, Reinherz EL, Schlossman SF. Human macrophage-lymphocyte interaction in proliferation to soluble antigen. I. Specific delection of lymphocyte proliferative activity on macrophage monolayers. Cell Immunol. 1980 Sep 15; 55(1):114-23.
    View in: PubMed
  405. Reinherz EL, O'Brien C, Rosenthal P, Schlossman SF. The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol. 1980 Sep; 125(3):1269-74.
    View in: PubMed
  406. Mehra V, Mason LH, Rothman W, Reinherz E, Schlossman SF, Bloom BR. Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol. 1980 Sep; 125(3):1183-8.
    View in: PubMed
  407. Nadler LM, Stashenko P, Hardy R, Kaplan WD, Button LN, Kufe DW, Antman KH, Schlossman SF. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 1980 Sep; 40(9):3147-54.
    View in: PubMed
  408. Reinherz EL, Schlossman SF. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14; 303(7):370-3.
    View in: PubMed
  409. Lipton JM, Reinherz EL, Kudisch M, Jackson PL, Schlossman SF, Nathan DG. Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation. J Exp Med. 1980 Aug 1; 152(2):350-60.
    View in: PubMed
  410. Breard J, Lazarus H, Schlossman SF. Generation and specificity of a heteroantiserum to human peripheral blood monocytes. Clin Immunol Immunopathol. 1980 Aug; 16(4):438-46.
    View in: PubMed
  411. Nadler LM, Stashenko P, Hardy R, Schlossman SF. A monoclonal antibody defining a lymphoma-associated antigen in man. J Immunol. 1980 Aug; 125(2):570-7.
    View in: PubMed
  412. Morimoto C, Reinherz EL, Abe T, Homma M, Schlossman SF. Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. Clin Immunol Immunopathol. 1980 Aug; 16(4):474-84.
    View in: PubMed
  413. Terhorst C, van Agthoven A, Reinherz E, Schlossman S. Biochemical analysis of human T lymphocyte differentiation antigens T4 and T5. Science. 1980 Jul 25; 209(4455):520-1.
    View in: PubMed
  414. Reinherz EL, Weiner HL, Hauser SL, Cohen JA, Distaso JA, Schlossman SF. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med. 1980 Jul 17; 303(3):125-9.
    View in: PubMed
  415. Reinherz EL, Morimoto C, Penta AC, Schlossman SF. Regulation of B cell immunoglobulin secretion by functional subsets of T lymphocytes in man. Eur J Immunol. 1980 Jul; 10(7):570-2.
    View in: PubMed
  416. Pesando JM, Ritz J, Levine H, Terhorst C, Lazarus H, Schlossman SF. Human leukemia-associated antigen: relation to a family of surface glycoproteins. J Immunol. 1980 Jun; 124(6):2794-9.
    View in: PubMed
  417. Nadler LM, Reinherz EL, Weinstein HJ, D'Orsi CJ, Schlossman SF. Heterogeneity of T-cell lymphoblastic malignancies. Blood. 1980 May; 55(5):806-10.
    View in: PubMed
  418. Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol. 1980 Apr; 124(4):1943-8.
    View in: PubMed
  419. Reinherz EL, Schlossman SF. The differentiation and function of human T lymphocytes. Cell. 1980 Apr; 19(4):821-7.
    View in: PubMed
  420. Reinherz EL, Kung PC, Breard JM, Goldstein G, Schlossman SF. T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved. J Immunol. 1980 Apr; 124(4):1883-7.
    View in: PubMed
  421. Reinherz EL, Moretta L, Roper M, Breard JM, Mingari MC, Cooper MD, Schlossman SF. Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med. 1980 Apr 1; 151(4):969-74.
    View in: PubMed
  422. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar; 77(3):1588-92.
    View in: PubMed
  423. Sallan SE, Ritz J, Pesando J, Gelber R, O'Brien C, Hitchcock S, Coral F, Schlossman SF. Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. Blood. 1980 Mar; 55(3):395-402.
    View in: PubMed
  424. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol. 1980 Mar; 124(3):1301-7.
    View in: PubMed
  425. Pratt DM, Schlossman SF, Strominger JL. Human T lymphocyte surface antigens: partial purification and characterization utilizing a high-titer heteroantiserum. J Immunol. 1980 Mar; 124(3):1449-61.
    View in: PubMed
  426. Ritz J, Pesando JM, Notis-McConarty J, Lazarus H, Schlossman SF. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature. 1980 Feb 7; 283(5747):583-5.
    View in: PubMed
  427. Bast RC, Knapp RC, Donahue VC, Thurston JG, Mitchell AK, Feeney M, Schlossman SF. Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cells. J Natl Cancer Inst. 1980 Feb; 64(2):365-72.
    View in: PubMed
  428. Reinherz EL, Hussey RE, Schlossman SF. Absence of expression of Ia antigen on human cytotoxic T cells. Immunogenetics. 1980; 11(4):421-6.
    View in: PubMed
  429. Nadler LM, Reinherz EL, Schlossman SF. The T lymphoblastic malignancies. Cancer Chemother Pharmacol. 1980; 4(1):11-5.
    View in: PubMed
  430. Pesando JM, Ritz J, Lazarus H, Costello SB, Sallan S, Schlossman SF. Leukemia-associated antigens in ALL. Blood. 1979 Dec; 54(6):1240-8.
    View in: PubMed
  431. Zimmermann R, Ozer H, DeWolf WC, Evans RL, Yunis EJ, Schlossman SF. The detection of Ia-like and DRw antigens on activated T cells. Transplant Proc. 1979 Dec; 11(4):1770-3.
    View in: PubMed
  432. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol. 1979 Dec; 123(6):2894-6.
    View in: PubMed
  433. Reinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G, Schlossman SF. Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med. 1979 Dec 1; 150(6):1472-82.
    View in: PubMed
  434. Reinherz EL, Rubinstein A, Geha RS, Strelkauskas AJ, Rosen FS, Schlossman SF. Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med. 1979 Nov 8; 301(19):1018-22.
    View in: PubMed
  435. Bast RC, Knapp RC, Mitchell AK, Thurston JG, Tucker RW, Schlossman SF. Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity. J Immunol. 1979 Nov; 123(5):1945-51.
    View in: PubMed
  436. Kung P, Goldstein G, Reinherz EL, Schlossman SF. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979 Oct 19; 206(4416):347-9.
    View in: PubMed
  437. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol. 1979 Sep; 123(3):1312-7.
    View in: PubMed
  438. Ferrara GB, Strelkauskas AJ, Longo A, McDowell J, Yunis EJ, Schlossman SF. Markers of human T cell subsets identified by alloantisera. J Immunol. 1979 Sep; 123(3):1272-7.
    View in: PubMed
  439. Strelkauskas AJ, Callery RT, Borel Y, Schlossman SF. Functional characteristics of human T-lymphocyte subsets identified by sera from patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1979 Sep; 14(1):47-55.
    View in: PubMed
  440. Reinherz EL, Nadler LM, Sallan SE, Schlossman SF. Subset derivation of T-cell acute lymphoblastic leukemia in man. J Clin Invest. 1979 Aug; 64(2):392-7.
    View in: PubMed
  441. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A. 1979 Aug; 76(8):4061-5.
    View in: PubMed
  442. Reinherz EL, Strelkauskas AJ, O'Brien C, Schlossman SF. Phenotypic and functional distinctions between the TH2+ and JRA+ T cell subsets in man. J Immunol. 1979 Jul; 123(1):83-6.
    View in: PubMed
  443. Ozer H, Strelkauskas AJ, Callery RT, Schlossman SF. A rapid method for the isolation of human peripheral null lymphocytes. Cell Immunol. 1979 Jul; 45(2):334-5.
    View in: PubMed
  444. Reinherz EL, Nadler LM, Rosenthal DS, Moloney WC, Schlossman SF. T-cell-subset characterization of human T-CLL. Blood. 1979 Jun; 53(6):1066-75.
    View in: PubMed
  445. Yanovich S, Marks SM, Rosenthal DS, Moloney WC, Schlossman SF. Cell-surface characteristics of hairy cell leukemia in seven patients. Cancer. 1979 Jun; 43(6):2348-51.
    View in: PubMed
  446. Breard J, Fuks A, Friedman SM, Schlossman SF, Chess L. The role of p23,30-bearing human macrophages in antigen-induced T lymphocyte responses. Cell Immunol. 1979 Jun; 45(1):108-19.
    View in: PubMed
  447. Reinherz EL, Parkman R, Rappeport J, Rosen FS, Schlossman SF. Aberrations of suppressor T cells in human graft-versus-host disease. N Engl J Med. 1979 May 10; 300(19):1061-8.
    View in: PubMed
  448. DeWolf WC, Schlossman SF, Yunis EJ. DRw antisera react with activated T cells. J Immunol. 1979 May; 122(5):1780-4.
    View in: PubMed
  449. Reinherz EL, Schlossman SF. Con A-inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man. J Immunol. 1979 Apr; 122(4):1335-41.
    View in: PubMed
  450. Ozer H, Strelkauskas AJ, Callery RT, Schlossman SF. The functional dissection of human peripheral null cells with respect to antibody-dependent cellular cytotoxicity and natural killing. Eur J Immunol. 1979 Feb; 9(2):112-8.
    View in: PubMed
  451. Yanovich S, Harris K, Sallan SE, Schlossman SF, Inbar M. Dynamic parameters of membrane lipids in normal and leukemic human lymphocytes isolated from peripheral blood and bone marrow. Cancer Res. 1978 Dec; 38(12):4654-61.
    View in: PubMed
  452. Campos Neto A, Schlossman SF. [Control of the specificity of B-lymphocytes (proceedings)]. An Acad Bras Cienc. 1978 Dec; 50(4):604.
    View in: PubMed
  453. Campos-Neto A, Schlossman SF, Levine H, Yanovski A, Yaron A. Specificity and genetic restrictions of the guinea-pig immune response to dinitrophenyl-lysyl-alanyl octapeptides. Immunology. 1978 Nov; 35(5):763-9.
    View in: PubMed
  454. Evans RL, Faldetta TJ, Humphreys RE, Pratt DM, Yunis EJ, Schlossman SF. Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med. 1978 Nov 1; 148(5):1440-5.
    View in: PubMed
  455. Strelkauskas AJ, Callery RT, McDowell J, Borel Y, Schlossman SF. Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci U S A. 1978 Oct; 75(10):5150-4.
    View in: PubMed
  456. Lazarus H, Barell EF, Krishan A, Livingston DM, Harris K, Schlossman SF, Chess L. Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia. Cancer Res. 1978 May; 38(5):1362-7.
    View in: PubMed
  457. Evans RL, Lazarus H, Penta AC, Schlossman SF. Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J Immunol. 1978 Apr; 120(4):1423-8.
    View in: PubMed
  458. Strelkauskas AJ, Schauf V, Wilson BS, Chess L, Schlossman SF. Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. J Immunol. 1978 Apr; 120(4):1278-82.
    View in: PubMed
  459. Marks SM, Yanovich S, Rosenthal DS, Moloney WC, Schlossman SF. Multimarker analysis of T-cell chronic lymphocytic leukemia. Blood. 1978 Mar; 51(3):435-8.
    View in: PubMed
  460. Evans RL, Chess L, Levine H, Schlossman SF. Antibody-dependent cellular cytotoxicity by allosensitized human T cells. J Exp Med. 1978 Feb 1; 147(2):605-10.
    View in: PubMed
  461. Campos-Neto A, Levine H, Schlossman SF. T-cell regulation of restricted B-cell responses. Adv Exp Med Biol. 1978; 98:403-17.
    View in: PubMed
  462. Strelkauskas AJ, Wilson BS, Callery RT, Chess L, Schlossman SF. T-cell regulation of human peripheral blood B-cells responsiveness. J Exp Med. 1977 Dec 1; 146(6):1765-72.
    View in: PubMed
  463. Stashenko PP, Bhan AK, Schlossman SF, McCluskey RT. Local transfer of delayed hypersensitivity and cutaneous basophil hypersensitivity. J Immunol. 1977 Dec; 119(6):1987-93.
    View in: PubMed
  464. Yaron A, Dunham EK, Stashenko PP, Campos-Neto A, Levine H, Schlossman SF. Immune ascites in the guinea pig: specificity of cells and antibody in an induced peritoneal exudate. J Immunol. 1977 Sep; 119(3):968-75.
    View in: PubMed
  465. Frei E, Schlossman S, Israel M. New approaches to the treatment of non-Hodgkin's lymphoma. Cancer Treat Rep. 1977 Sep; 61(6):1209-17.
    View in: PubMed
  466. Greenberger JS, Campos-Neto A, Parkman R, Moloney WC, Karpas A, Schlossman SF, Rosenthal DS. Immunologic detection of intracellular and cell-surface lysozyme with human and experimental leukemic leukocytes. Clin Immunol Immunopathol. 1977 Sep; 8(2):318-34.
    View in: PubMed
  467. Reinisch CL, Andrew SL, Schlossman SF. Suppressor cell regulation of immune response to tumors: abrogation by adult thymectomy. Proc Natl Acad Sci U S A. 1977 Jul; 74(7):2989-92.
    View in: PubMed
  468. Greenberg LJ, Reinsmoen NL, Noreen H, Chess L, Schlossman SF, Yunis EJ. Serologic analysis of MLC determinants. Transplant Proc. 1977 Mar; 9(1):865-68.
    View in: PubMed
  469. Elboim CM, Reinisch CL, Schlossman SF. T and B lymphocyte migration into syngeneic tumors. J Immunol. 1977 Mar; 118(3):1042-8.
    View in: PubMed
  470. Friedman SM, Breard JM, Humphreys RE, Strominger JL, Schlossman SF, Chess L. Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p23, 30 antigen. Proc Natl Acad Sci U S A. 1977 Feb; 74(2):711-5.
    View in: PubMed
  471. Stashenko PP, Schlossman SF. Antigen recognition: the specificity of an isolated T lymphocyte population. J Immunol. 1977 Feb; 118(2):544-50.
    View in: PubMed
  472. Chess L, Schlossman SF. Human lymphocyte subpopulations. Adv Immunol. 1977; 25:213-41.
    View in: PubMed
  473. Chess L, Schlossman SF. Functional analysis of distinct human T-cell subsets bearing unique differentiation antigens. Contemp Top Immunobiol. 1977; 7:363-79.
    View in: PubMed
  474. Evans RL, Breard JM, Lazarus H, Schlossman SF, Chess L. Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens. J Exp Med. 1977 Jan 1; 145(1):221-33.
    View in: PubMed
  475. Reinisch CL, Schlossman SF. Potentiation of cytotoxic T-cell function by virus. J Natl Cancer Inst. 1976 Dec; 57(6):1277-81.
    View in: PubMed
  476. Sondel PM, O'Brien C, Porter L, Schlossman SF, Chess L. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. J Immunol. 1976 Dec; 117(6):2197-203.
    View in: PubMed
  477. Chess L, Evans R, Humphreys RE, Strominger JL, Schlossman SF. Inhibition of antibody-dependent cellular cytotoxicity and immunoglobulin synthesis by an antiserum prepared against a human B-cell Ia-like molecule. J Exp Med. 1976 Jul 1; 144(1):113-22.
    View in: PubMed
  478. Humphreys RE, McCune JM, Chess L, Herrman HC, Malenka DJ, Mann DL, Parham P, Schlossman SF, Strominger JL. Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen. J Exp Med. 1976 Jul 1; 144(1):98-112.
    View in: PubMed
  479. Civin CI, Levine HB, Williamson AR, Schlossman SF. The effects of antigen dose and adjuvant on the antibody response; amplification of restricted B cell clones. J Immunol. 1976 May; 116(5):1400-6.
    View in: PubMed
  480. Schlossman SF, Chess L, Humphreys RE, Strominger JL. Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci U S A. 1976 Apr; 73(4):1288-92.
    View in: PubMed
  481. Reinisch CL, Gleiner NA, Schlossman SF. Adjuvant regulation of T cell function. J Immunol. 1976 Mar; 116(3):710-5.
    View in: PubMed
  482. Brier AM, Chess L, Schlossman SF. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells. J Clin Invest. 1975 Dec; 56(6):1580-6.
    View in: PubMed
  483. Chess L, Levine H, MacDermott RP, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. VI. Further characterization of the surface Ig negative, E rosette negative (null cell) subset. J Immunol. 1975 Dec; 115(6):1483-7.
    View in: PubMed
  484. Borel Y, Reinisch CL, Schlossman SF. T and B cell in hapten-specific carrier-determined tolerance. J Exp Med. 1975 Nov 1; 142(5):1254-62.
    View in: PubMed
  485. Mac Dermott RP, Chess L, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. V. Isolation and functional analysis of a surface Ig negative, E rosette negative subset. Clin Immunol Immunopathol. 1975 Sep; 4(3):415-24.
    View in: PubMed
  486. Sondel PM, Chess L, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. IV. Stimulation of MLC and CML by human T cells. Cell Immunol. 1975 Aug; 18(2):351-9.
    View in: PubMed
  487. Chess L, Rocklin RE, MacDermott RP, David JR, Schlossman SF. Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes. J Immunol. 1975 Jul; 115(1):315-7.
    View in: PubMed
  488. Bhan AK, Reinisch CL, Levey RH, McCluskey RT, Schlossman SF. T-cell migration into allografts. J Exp Med. 1975 May 1; 141(5):1210-5.
    View in: PubMed
  489. Sondel PM, Chess L, MacDermott RP, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone. J Immunol. 1975 Mar; 114(3):982-7.
    View in: PubMed
  490. Rocklin RE, Chess L, MacDermott RP, Schlossman SF, David JR. Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes. Rheumatology. 1975; 6:98-105.
    View in: PubMed
  491. Frei E, Schlossman S. Editorial: BCG and lymphoma. N Engl J Med. 1974 Dec 5; 291(23):1255-6.
    View in: PubMed
  492. Kasdon EJ, Jones G, Schlossman SF. Experimental intradermal granuloma formation. J Invest Dermatol. 1974 Nov; 63(5):411-4.
    View in: PubMed
  493. Rocklin RE, MacDermott RP, Chess L, Schlossman SF, David JR. Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med. 1974 Nov 1; 140(5):1303-16.
    View in: PubMed
  494. Chess L, MacDermott RP, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. II. Antigen triggering of T and B cells in vitro. J Immunol. 1974 Oct; 113(4):1122-7.
    View in: PubMed
  495. Chess L, MacDermott RP, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol. 1974 Oct; 113(4):1113-21.
    View in: PubMed
  496. Kapp JA, Pierce CW, Schlossman S, Benacerraf B. Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). J Exp Med. 1974 Sep 1; 140(3):648-59.
    View in: PubMed
  497. Dunham EK, Schlossman SF, Benacerraf B. Interactions between two antigens governed by the poly-L-lysine gene: failure of one to inhibit competitively an in vitro response to the other. Proc Soc Exp Biol Med. 1974 Feb; 145(2):537-41.
    View in: PubMed
  498. Yaron A, Dunham EK, Schlossman SF. Synthesis and immunological properties of the oligolysyl-N-epsilon-dinitrophenyllysine and oligolysylalanylalanylalanyl-N-epsilon-dinitrophenyllysine peptide series. Biochemistry. 1974 Jan 15; 13(2):347-54.
    View in: PubMed
  499. Jaffer AM, Jones G, Kasdon EJ, Schlossman SF. Local transfer of delayed hypersensitivity by T lymphocytes. J Immunol. 1973 Oct; 111(4):1268-9.
    View in: PubMed
  500. Kasdon EJ, Schlossman SF. An experimental model of pulmonary arterial granulomatous inflammation. Am J Pathol. 1973 Jun; 71(3):365-72.
    View in: PubMed
  501. Schlossman SF, Hudson L. Specific purification of lymphocyte populations on a digestible immunoabsorbent. J Immunol. 1973 Jan; 110(1):313-9.
    View in: PubMed
  502. Levin HA, Herman J, Levine H, Schlossman SF. The secondary immune response: the specificity of lymph node cells and antibody. J Immunol. 1972 Feb; 108(2):538-46.
    View in: PubMed
  503. Schlossman SF. Antigen recognition: the specificity of T cells involved in the cellular immune response. Transplant Rev. 1972; 10:97-111.
    View in: PubMed
  504. Schlossman SF, Levin HA, Rocklin RE, David JR. The compartmentalization of antigen-reactive lymphocytes in desensitized guinea pigs. J Exp Med. 1971 Sep 1; 134(3 Pt 1):741-50.
    View in: PubMed
  505. Levin HA, Levine H, Schlossman SF. Antigen recognition and antibody specificity. Carrier specificity and genetic control of anti-dinitrophenyl-oligolysine antibody. J Exp Med. 1971 Jun 1; 133(6):1199-218.
    View in: PubMed
  506. Borel Y, Schlossman S. Studies on the cellular basis for partial tolerance: antigen-specific suppression of antigen-induced thymidine-2-14C incorporation in vitro. J Immunol. 1971 Feb; 106(2):397-401.
    View in: PubMed
  507. Schlossman SF, Levine H. The specificity of the secondary immune response: characterization of the antibody produced to cross-reactive antigens. Cell Immunol. 1970 Oct; 1(4):419-29.
    View in: PubMed
  508. Besdine RW, Schlossman SF. In vitro lymphocyte responses. N Engl J Med. 1970 Jun 11; 282(24):1371-2.
    View in: PubMed
  509. Levin HA, Levine H, Schlossman SF. Studies on the specificity and affinity of alpha, DNP-oligolysine antibody: a basis for questioning the role of cell-bound antibody in cellular recognition of antigen. J Immunol. 1970 Jun; 104(6):1377-83.
    View in: PubMed
  510. Schlossman SF, Yaron A. Immunochemical studies on the specificity of cellular and antibody-mediated immune reactions. Ann N Y Acad Sci. 1970 Feb 13; 169(1):108-15.
    View in: PubMed
  511. Schlossman SF, Herman J, Yaron A. Antigen recognition: in vitro studies on the specificity of the cellular immune response. J Exp Med. 1969 Nov 1; 130(5):1031-45.
    View in: PubMed
  512. David JR, Schlossman SF. Immunochemical studies on the specificity of cellular hypersensitivity. The in vitro inhibition of peritoneal exudate cell migration by cehmically defined antigens. J Exp Med. 1968 Dec 1; 128(6):1451-9.
    View in: PubMed
  513. Stulbarg M, Schlossman SF. The specificity of antigen-induced thymidine-2-14C incorporation into lymph node cells frrom sensitized animals. J Immunol. 1968 Oct; 101(4):764-9.
    View in: PubMed
  514. Yaron A, Schlossman SF. Preparation and immunologic properties of stereospecific alpha-dinitrophenylnonalysines. Biochemistry. 1968 Jul; 7(7):2673-81.
    View in: PubMed
  515. Schlossman SF, Levine H, Yaron A. Studies on the specificity of antibody to 2,4-Dini-trophenyl-poly-L-lysines. Biochemistry. 1968 Jan; 7(1):1-7.
    View in: PubMed
  516. Schlossman SF. The immune response. Some unifying concepts. N Engl J Med. 1967 Dec 21; 277(25):1355-61.
    View in: PubMed
  517. Schlossman SF, Levine H. Desensitization to delayed hypersensitivity reactions. With special reference to the requirement for an immunogenic molecule. J Immunol. 1967 Jul; 99(1):111-4.
    View in: PubMed
  518. Schlossman SF, Levine H. Immunochemical studies on delayed and arthus-type hypersensitivity reactions. I. The relationship between antigenic determinant size and antibody combining site size. J Immunol. 1967 Feb; 98(2):211-9.
    View in: PubMed
  519. Sober HA, Schlossman SF, Yaron A, Latt SA RUSHIZKY GW. Protein-nucleic acid interaction. I. Nuclease-resistant polylysine-ribonculeic acid complexes. Biochemistry. 1966 Nov; 5(11):3608-16.
    View in: PubMed
  520. Schlossman SF, Ben-Efraim S, Yaron A, Sober HA. Immunochemical studies on the antigenic determinants required to elicit delayed and immediate hypersensitivity reactions. J Exp Med. 1966 Jun 1; 123(6):1083-95.
    View in: PubMed
  521. Schlossman SF, Yaron A, Ben-Efraim S, Sober HA. Immunogenicity of a series of alpha,N-DNP-L-lysines. Biochemistry. 1965 Aug; 4(8):1638-45.
    View in: PubMed
  522. BURNINGHAM RA, RESTREPO A, PUGH RP, BROWN EB, SCHLOSSMAN SF, KHURI PD, LESSNER HE, HARRINGTON WJ. WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS. N Engl J Med. 1964 May 28; 270:1160-6.
    View in: PubMed
  523. SCHLOSSMAN SF, ZARNITZ ML, KABAT EA, KEILICH G, WALLENFELS K. IMMUNOCHEMICAL STUDIES ON PULLULAN, AN EXTRACELLULAR POLYSACCHARIDE FROM PULLULARIA PULLULANS. J Immunol. 1963 Jul; 91:50-7.
    View in: PubMed
  524. SCHLOSSMAN SF, KABAT EA. Specific fractionation of a population of antidextran molecules with combining sites of various sizes. J Exp Med. 1962 Oct 1; 116:535-52.
    View in: PubMed
  525. BENACERRAF B, SEBESTYEN MM, SCHLOSSMAN S. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system. J Exp Med. 1959 Jul 1; 110(1):27-48.
    View in: PubMed
  526. SCHLOSSMAN S, STETSON CA. Vascularization of the cornea during delayed hypersensitivity reactions. J Immunol. 1957 Sep; 79(3):208-10.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Schlossman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_